US20120285690A1 - Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces - Google Patents
Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces Download PDFInfo
- Publication number
- US20120285690A1 US20120285690A1 US13/239,491 US201113239491A US2012285690A1 US 20120285690 A1 US20120285690 A1 US 20120285690A1 US 201113239491 A US201113239491 A US 201113239491A US 2012285690 A1 US2012285690 A1 US 2012285690A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- concentration
- desensitizing
- agent
- subterranean formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 142
- 238000000034 method Methods 0.000 title claims abstract description 102
- 239000000203 mixture Substances 0.000 title claims description 14
- 238000005755 formation reaction Methods 0.000 title description 121
- 239000012530 fluid Substances 0.000 claims abstract description 303
- 239000003975 dentin desensitizing agent Substances 0.000 claims abstract description 116
- 238000011282 treatment Methods 0.000 claims abstract description 96
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 66
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 150000003839 salts Chemical class 0.000 claims description 44
- 239000000377 silicon dioxide Substances 0.000 claims description 29
- 229920005989 resin Polymers 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 23
- 239000000839 emulsion Substances 0.000 claims description 20
- 230000004048 modification Effects 0.000 claims description 20
- 238000012986 modification Methods 0.000 claims description 20
- 239000004094 surface-active agent Substances 0.000 claims description 18
- 239000002105 nanoparticle Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 15
- 150000007522 mineralic acids Chemical class 0.000 claims description 13
- 230000000087 stabilizing effect Effects 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 230000002939 deleterious effect Effects 0.000 claims description 12
- 239000002738 chelating agent Substances 0.000 claims description 10
- 239000011859 microparticle Substances 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- 150000007529 inorganic bases Chemical class 0.000 claims description 8
- 230000000149 penetrating effect Effects 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 8
- 229920006317 cationic polymer Polymers 0.000 claims description 6
- 239000010695 polyglycol Substances 0.000 claims description 5
- 229920000151 polyglycol Polymers 0.000 claims description 5
- 239000006260 foam Substances 0.000 claims description 4
- 229920000867 polyelectrolyte Polymers 0.000 claims description 3
- 229920000223 polyglycerol Polymers 0.000 claims description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 4
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 claims 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 claims 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 51
- 235000010755 mineral Nutrition 0.000 description 51
- 239000011707 mineral Substances 0.000 description 51
- 239000002585 base Substances 0.000 description 50
- -1 but not limited to Substances 0.000 description 43
- 239000000243 solution Substances 0.000 description 25
- 239000000654 additive Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 230000008901 benefit Effects 0.000 description 21
- 239000004927 clay Substances 0.000 description 20
- 229920000642 polymer Polymers 0.000 description 20
- 239000000463 material Substances 0.000 description 19
- 230000000996 additive effect Effects 0.000 description 17
- 206010017076 Fracture Diseases 0.000 description 16
- 150000007524 organic acids Chemical class 0.000 description 16
- 238000011105 stabilization Methods 0.000 description 13
- 208000010392 Bone Fractures Diseases 0.000 description 12
- 235000005985 organic acids Nutrition 0.000 description 12
- 238000000586 desensitisation Methods 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 150000001768 cations Chemical class 0.000 description 8
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 8
- 125000002091 cationic group Chemical group 0.000 description 7
- 230000035699 permeability Effects 0.000 description 7
- 239000011435 rock Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 5
- 150000007530 organic bases Chemical class 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000004576 sand Substances 0.000 description 5
- 150000004760 silicates Chemical class 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 4
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 235000015076 Shorea robusta Nutrition 0.000 description 4
- 244000166071 Shorea robusta Species 0.000 description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 4
- 239000004115 Sodium Silicate Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 4
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229910001919 chlorite Inorganic materials 0.000 description 4
- 229910052619 chlorite group Inorganic materials 0.000 description 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 4
- 239000003245 coal Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 229910052906 cristobalite Inorganic materials 0.000 description 4
- 239000004088 foaming agent Substances 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- 229920001519 homopolymer Polymers 0.000 description 4
- 229910052900 illite Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920000768 polyamine Polymers 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 229910000077 silane Inorganic materials 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 4
- 229910052911 sodium silicate Inorganic materials 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000004111 Potassium silicate Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 239000004280 Sodium formate Substances 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 3
- 229910001863 barium hydroxide Inorganic materials 0.000 description 3
- 229910052792 caesium Inorganic materials 0.000 description 3
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 3
- ATZQZZAXOPPAAQ-UHFFFAOYSA-M caesium formate Chemical compound [Cs+].[O-]C=O ATZQZZAXOPPAAQ-UHFFFAOYSA-M 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 3
- 239000001639 calcium acetate Substances 0.000 description 3
- 235000011092 calcium acetate Nutrition 0.000 description 3
- 229960005147 calcium acetate Drugs 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
- 239000000920 calcium hydroxide Substances 0.000 description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 3
- 238000005341 cation exchange Methods 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 229910052681 coesite Inorganic materials 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 3
- 239000010433 feldspar Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 150000001282 organosilanes Chemical class 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 3
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 3
- 229910052913 potassium silicate Inorganic materials 0.000 description 3
- 235000019353 potassium silicate Nutrition 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 150000004756 silanes Chemical class 0.000 description 3
- 229910021647 smectite Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 3
- 235000019254 sodium formate Nutrition 0.000 description 3
- 229910052682 stishovite Inorganic materials 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 229910052905 tridymite Inorganic materials 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- QYIGOGBGVKONDY-UHFFFAOYSA-N 1-(2-bromo-5-chlorophenyl)-3-methylpyrazole Chemical compound N1=C(C)C=CN1C1=CC(Cl)=CC=C1Br QYIGOGBGVKONDY-UHFFFAOYSA-N 0.000 description 2
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 2
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 239000005700 Putrescine Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229910052787 antimony Inorganic materials 0.000 description 2
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 2
- NJGBSFDVMQSDTF-UHFFFAOYSA-K antimony(3+);triformate Chemical compound [Sb+3].[O-]C=O.[O-]C=O.[O-]C=O NJGBSFDVMQSDTF-UHFFFAOYSA-K 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- MFBGWESXOIGYSS-UHFFFAOYSA-K bismuth;triformate Chemical compound [Bi+3].[O-]C=O.[O-]C=O.[O-]C=O MFBGWESXOIGYSS-UHFFFAOYSA-K 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- ZOAIGCHJWKDIPJ-UHFFFAOYSA-M caesium acetate Chemical compound [Cs+].CC([O-])=O ZOAIGCHJWKDIPJ-UHFFFAOYSA-M 0.000 description 2
- NLSCHDZTHVNDCP-UHFFFAOYSA-N caesium nitrate Chemical compound [Cs+].[O-][N+]([O-])=O NLSCHDZTHVNDCP-UHFFFAOYSA-N 0.000 description 2
- FLJPGEWQYJVDPF-UHFFFAOYSA-L caesium sulfate Chemical compound [Cs+].[Cs+].[O-]S([O-])(=O)=O FLJPGEWQYJVDPF-UHFFFAOYSA-L 0.000 description 2
- 229910001622 calcium bromide Inorganic materials 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 2
- 239000004281 calcium formate Substances 0.000 description 2
- 235000019255 calcium formate Nutrition 0.000 description 2
- 229940044172 calcium formate Drugs 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000002734 clay mineral Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- JVLRYPRBKSMEBF-UHFFFAOYSA-K diacetyloxystibanyl acetate Chemical compound [Sb+3].CC([O-])=O.CC([O-])=O.CC([O-])=O JVLRYPRBKSMEBF-UHFFFAOYSA-K 0.000 description 2
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- WOXXJEVNDJOOLV-UHFFFAOYSA-N ethenyl-tris(2-methoxyethoxy)silane Chemical compound COCCO[Si](OCCOC)(OCCOC)C=C WOXXJEVNDJOOLV-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 229910052610 inosilicate Inorganic materials 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229910052622 kaolinite Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- GMDNUWQNDQDBNQ-UHFFFAOYSA-L magnesium;diformate Chemical compound [Mg+2].[O-]C=O.[O-]C=O GMDNUWQNDQDBNQ-UHFFFAOYSA-L 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000002071 nanotube Substances 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- CPRMKOQKXYSDML-UHFFFAOYSA-M rubidium hydroxide Chemical compound [OH-].[Rb+] CPRMKOQKXYSDML-UHFFFAOYSA-M 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004317 sodium nitrate Substances 0.000 description 2
- 235000010344 sodium nitrate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 229940063675 spermine Drugs 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 2
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 description 2
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 2
- BPSIOYPQMFLKFR-VIFPVBQESA-N trimethoxy-[3-[[(2r)-oxiran-2-yl]methoxy]propyl]silane Chemical compound CO[Si](OC)(OC)CCCOC[C@H]1CO1 BPSIOYPQMFLKFR-VIFPVBQESA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000005050 vinyl trichlorosilane Substances 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 229940102001 zinc bromide Drugs 0.000 description 2
- 229940006486 zinc cation Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 2
- UUIPAJHTKDSSOK-UHFFFAOYSA-N (2-nonylphenyl) dihydrogen phosphate Chemical class CCCCCCCCCC1=CC=CC=C1OP(O)(O)=O UUIPAJHTKDSSOK-UHFFFAOYSA-N 0.000 description 1
- OGZPYBBKQGPQNU-DABLZPOSSA-N (e)-n-[bis[[(e)-butan-2-ylideneamino]oxy]-methylsilyl]oxybutan-2-imine Chemical compound CC\C(C)=N\O[Si](C)(O\N=C(/C)CC)O\N=C(/C)CC OGZPYBBKQGPQNU-DABLZPOSSA-N 0.000 description 1
- XYOMMVNZIAGSMW-UHFFFAOYSA-N (prop-2-enoylamino)methyl propane-1-sulfonate Chemical compound CCCS(=O)(=O)OCNC(=O)C=C XYOMMVNZIAGSMW-UHFFFAOYSA-N 0.000 description 1
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 description 1
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- SZGNDBVUPCXUDY-UHFFFAOYSA-N 2-(1-butoxypentan-2-yloxymethyl)oxirane Chemical compound CCCCOCC(CCC)OCC1CO1 SZGNDBVUPCXUDY-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FKWUKIQLDIORHQ-UHFFFAOYSA-M 2-(3-ethyl-2-heptadec-8-enyl-4,5-dihydroimidazol-1-ium-1-yl)ethanol;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.CCCCCCCCC=CCCCCCCCC1=[N+](CCO)CCN1CC FKWUKIQLDIORHQ-UHFFFAOYSA-M 0.000 description 1
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- QNIRRHUUOQAEPB-UHFFFAOYSA-N 2-(prop-2-enoylamino)butane-2-sulfonic acid Chemical class CCC(C)(S(O)(=O)=O)NC(=O)C=C QNIRRHUUOQAEPB-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- QLKGUVGAXDXFFW-UHFFFAOYSA-M 2-hydroxyethyl(trimethyl)azanium;acetate Chemical group CC([O-])=O.C[N+](C)(C)CCO QLKGUVGAXDXFFW-UHFFFAOYSA-M 0.000 description 1
- YTLUDYJZQJMFKO-UHFFFAOYSA-M 2-hydroxypropyl(trimethyl)azanium;acetate Chemical group CC([O-])=O.CC(O)C[N+](C)(C)C YTLUDYJZQJMFKO-UHFFFAOYSA-M 0.000 description 1
- VSSGDAWBDKMCMI-UHFFFAOYSA-N 2-methyl-2-(2-methylprop-2-enoylamino)propane-1-sulfonic acid Chemical compound CC(=C)C(=O)NC(C)(C)CS(O)(=O)=O VSSGDAWBDKMCMI-UHFFFAOYSA-N 0.000 description 1
- JNDVNJWCRZQGFQ-UHFFFAOYSA-N 2-methyl-N,N-bis(methylamino)hex-2-enamide Chemical compound CCCC=C(C)C(=O)N(NC)NC JNDVNJWCRZQGFQ-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- LCFVJGUPQDGYKZ-UHFFFAOYSA-N Bisphenol A diglycidyl ether Chemical compound C=1C=C(OCC2OC2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 LCFVJGUPQDGYKZ-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241001449342 Chlorocrambe hastata Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 208000003044 Closed Fractures Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical class [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- FENPGMSLABHLHZ-UHFFFAOYSA-N OCCC(CCCCCCCC=C/CCCCCCCCCCCCN)CCO Chemical compound OCCC(CCCCCCCC=C/CCCCCCCCCCCCN)CCO FENPGMSLABHLHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 1
- 229910052774 Proactinium Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 241000388430 Tara Species 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- XYZGDYPGGXDMGG-QVTWQEFQSA-J [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@H](NC(C([O-])=O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@H](NC(C([O-])=O)C([O-])=O)C([O-])=O XYZGDYPGGXDMGG-QVTWQEFQSA-J 0.000 description 1
- YWMWZKYVGNWJPU-UHFFFAOYSA-N [bis[6-[bis(phosphonomethyl)amino]hexyl]amino]methylphosphonic acid Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCCCCCN(CP(O)(=O)O)CCCCCCN(CP(O)(O)=O)CP(O)(O)=O YWMWZKYVGNWJPU-UHFFFAOYSA-N 0.000 description 1
- TVJPBVNWVPUZBM-UHFFFAOYSA-N [diacetyloxy(methyl)silyl] acetate Chemical compound CC(=O)O[Si](C)(OC(C)=O)OC(C)=O TVJPBVNWVPUZBM-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- HEHRHMRHPUNLIR-UHFFFAOYSA-N aluminum;hydroxy-[hydroxy(oxo)silyl]oxy-oxosilane;lithium Chemical compound [Li].[Al].O[Si](=O)O[Si](O)=O.O[Si](=O)O[Si](O)=O HEHRHMRHPUNLIR-UHFFFAOYSA-N 0.000 description 1
- CNLWCVNCHLKFHK-UHFFFAOYSA-N aluminum;lithium;dioxido(oxo)silane Chemical compound [Li+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O CNLWCVNCHLKFHK-UHFFFAOYSA-N 0.000 description 1
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- RHZUVFJBSILHOK-UHFFFAOYSA-N anthracen-1-ylmethanolate Chemical compound C1=CC=C2C=C3C(C[O-])=CC=CC3=CC2=C1 RHZUVFJBSILHOK-UHFFFAOYSA-N 0.000 description 1
- 239000003830 anthracite Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical class [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 229910001570 bauxite Inorganic materials 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229910052614 beryl Inorganic materials 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- CMPOVQUVPYXEBN-UHFFFAOYSA-N bis(2-hydroxyethyl)-methylazanium;chloride Chemical compound Cl.OCCN(C)CCO CMPOVQUVPYXEBN-UHFFFAOYSA-N 0.000 description 1
- MRNZSTMRDWRNNR-UHFFFAOYSA-N bis(hexamethylene)triamine Chemical class NCCCCCCNCCCCCCN MRNZSTMRDWRNNR-UHFFFAOYSA-N 0.000 description 1
- 239000002802 bituminous coal Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- LYQFWZFBNBDLEO-UHFFFAOYSA-M caesium bromide Chemical compound [Br-].[Cs+] LYQFWZFBNBDLEO-UHFFFAOYSA-M 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000011852 carbon nanoparticle Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- HOPSCVCBEOCPJZ-UHFFFAOYSA-N carboxymethyl(trimethyl)azanium;chloride Chemical group [Cl-].C[N+](C)(C)CC(O)=O HOPSCVCBEOCPJZ-UHFFFAOYSA-N 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229940006165 cesium cation Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- QZVSYHUREAVHQG-UHFFFAOYSA-N diberyllium;silicate Chemical compound [Be+2].[Be+2].[O-][Si]([O-])([O-])[O-] QZVSYHUREAVHQG-UHFFFAOYSA-N 0.000 description 1
- 229910001649 dickite Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- PZZHMLOHNYWKIK-UHFFFAOYSA-N eddha Chemical compound C=1C=CC=C(O)C=1C(C(=O)O)NCCNC(C(O)=O)C1=CC=CC=C1O PZZHMLOHNYWKIK-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229910052634 enstatite Inorganic materials 0.000 description 1
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000010881 fly ash Substances 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 239000007849 furan resin Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229910052631 glauconite Inorganic materials 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229910052621 halloysite Inorganic materials 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000004693 imidazolium salts Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910001608 iron mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000003077 lignite Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940096405 magnesium cation Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- BBCCCLINBSELLX-UHFFFAOYSA-N magnesium;dihydroxy(oxo)silane Chemical compound [Mg+2].O[Si](O)=O BBCCCLINBSELLX-UHFFFAOYSA-N 0.000 description 1
- FMUNKBAIXLTEGC-UHFFFAOYSA-L magnesium;n,n-diethylethanamine;dichloride Chemical compound [Mg+2].[Cl-].[Cl-].CCN(CC)CC FMUNKBAIXLTEGC-UHFFFAOYSA-L 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Chemical class 0.000 description 1
- 229910052748 manganese Chemical class 0.000 description 1
- 239000011572 manganese Chemical class 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 229910052914 metal silicate Inorganic materials 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000476 molybdenum oxide Inorganic materials 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- HDNXAGOHLKHJOA-UHFFFAOYSA-N n-[bis(cyclohexylamino)-methylsilyl]cyclohexanamine Chemical compound C1CCCCC1N[Si](NC1CCCCC1)(C)NC1CCCCC1 HDNXAGOHLKHJOA-UHFFFAOYSA-N 0.000 description 1
- 239000002103 nanocoating Substances 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 229910052605 nesosilicate Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 239000010450 olivine Substances 0.000 description 1
- 229910052609 olivine Inorganic materials 0.000 description 1
- 239000006259 organic additive Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 150000004762 orthosilicates Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 description 1
- CMOAHYOGLLEOGO-UHFFFAOYSA-N oxozirconium;dihydrochloride Chemical compound Cl.Cl.[Zr]=O CMOAHYOGLLEOGO-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- OSBMVGFXROCQIZ-UHFFFAOYSA-I pentasodium;[bis(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O OSBMVGFXROCQIZ-UHFFFAOYSA-I 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910052670 petalite Inorganic materials 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 150000004714 phosphonium salts Chemical group 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 238000004375 physisorption Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910001744 pollucite Inorganic materials 0.000 description 1
- 229920001485 poly(butyl acrylate) polymer Polymers 0.000 description 1
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000333 poly(propyleneimine) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 229910052611 pyroxene Inorganic materials 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical class [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000276 sauconite Inorganic materials 0.000 description 1
- 239000002455 scale inhibitor Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910052642 spodumene Inorganic materials 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- UUCCCPNEFXQJEL-UHFFFAOYSA-L strontium dihydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 description 1
- 229910001866 strontium hydroxide Inorganic materials 0.000 description 1
- 239000003476 subbituminous coal Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 229920006029 tetra-polymer Polymers 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- INETXKGLHYNTHK-AQWWNALJSA-N tetrakis[(e)-butan-2-ylideneamino] silicate Chemical compound CC\C(C)=N\O[Si](O\N=C(/C)CC)(O\N=C(/C)CC)O\N=C(/C)CC INETXKGLHYNTHK-AQWWNALJSA-N 0.000 description 1
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical class [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Chemical class OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229910052889 tremolite Inorganic materials 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- CPWJKGIJFGMVPL-UHFFFAOYSA-K tricesium;phosphate Chemical compound [Cs+].[Cs+].[Cs+].[O-]P([O-])([O-])=O CPWJKGIJFGMVPL-UHFFFAOYSA-K 0.000 description 1
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 1
- ULEFFCDROVNTRO-UHFFFAOYSA-N trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+) Chemical compound [Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3].O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O ULEFFCDROVNTRO-UHFFFAOYSA-N 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- GXQFALJDHPPWKR-UHFFFAOYSA-L trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;sulfate Chemical group [O-]S([O-])(=O)=O.CC(=C)C(=O)OCC[N+](C)(C)C.CC(=C)C(=O)OCC[N+](C)(C)C GXQFALJDHPPWKR-UHFFFAOYSA-L 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical group OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 229910052844 willemite Inorganic materials 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910052845 zircon Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 229910006297 γ-Fe2O3 Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/56—Compositions for consolidating loose sand or the like around wells without excessively decreasing the permeability thereof
- C09K8/57—Compositions based on water or polar solvents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/60—Compositions for stimulating production by acting on the underground formation
- C09K8/607—Compositions for stimulating production by acting on the underground formation specially adapted for clay formations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/60—Compositions for stimulating production by acting on the underground formation
- C09K8/607—Compositions for stimulating production by acting on the underground formation specially adapted for clay formations
- C09K8/608—Polymer compositions
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/60—Compositions for stimulating production by acting on the underground formation
- C09K8/62—Compositions for forming crevices or fractures
- C09K8/66—Compositions based on water or polar solvents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/60—Compositions for stimulating production by acting on the underground formation
- C09K8/62—Compositions for forming crevices or fractures
- C09K8/66—Compositions based on water or polar solvents
- C09K8/68—Compositions based on water or polar solvents containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2208/00—Aspects relating to compositions of drilling or well treatment fluids
- C09K2208/10—Nanoparticle-containing well treatment fluids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2208/00—Aspects relating to compositions of drilling or well treatment fluids
- C09K2208/12—Swell inhibition, i.e. using additives to drilling or well treatment fluids for inhibiting clay or shale swelling or disintegrating
Definitions
- the present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- formation faces refers to any portion of the formation that is exposed to, for example, a treatment fluid, and includes fracture faces and platelet faces.
- ductile refers to becoming able to deform under pressure.
- Troublesome formations may include, but not be limited to, water-sensitive clays, tight gas formations, shales, and coal beds.
- the terms “clays” and “water-sensitive clays” are used herein interchangeably to generally indicate water-sensitive clays that, when contacted by aqueous fluids in disequilibrium with the minerals in the formation, tend to swell and/or migrate.
- the clay content of the formations may be a single species of a clay mineral or several species, including, but not limited to, the mixed-layer types of clay.
- the term “tight gas” refers to gas found in sedimentary rock that is cemented together so that permeabilities are relatively low.
- the term “shale” refers to a sedimentary rock formed from the consolidation of fine clay and silt materials into laminated, thin bedding planes.
- “coal bed” refers to a rock formation that may be comprised of, inter alia, one or more types of coal, including, but not limited to, peat, lignite, sub-bituminous coal, bituminous coal, anthracite, and graphite.
- the chemical and physical changes in the formation faces often results in the blockage and/or closure of passageways that penetrate the subterranean formation (e.g., fracture network, pore throats, etc.), thereby causing a loss in permeability of the formation.
- This loss in permeability impairs the flow of fluid through the wellbore and, in some cases, may even completely block the flow of fluids through portions of the formation. Loss in permeability often leads to a decrease in the production for the well.
- some changes in the formation faces e.g., migrating fines, can be produced with the formation fluids, thereby presenting potential abrasion and other problems with the production equipment and potential reduction in fracture conductivity.
- various methods have been developed for treating problematic formations to desensitize the formation faces from chemical and physical changes. For example, it has been common practice to add salts to aqueous drilling fluids. The salts adsorb to the clay surfaces in an ion exchange process that can reduce the swelling and/or migration of the clays. Another method used to deter migration is to coat the region with a polymer and/or a consolidating resin in order to physically block the migration of the clays.
- the term “desensitizing solution” as used herein refers to any solution or suspension used to reduce the sensitivity of minerals within a subterranean formation to chemical and physical changes.
- the terms “desensitizing components” and “desensitizing agents” as used herein refer to the components of a desensitizing solution that interacts with formation faces to reduce the sensitivity of minerals to chemical and physical changes.
- the desensitizing agents are removed from the desensitizing solution by the formation faces through known mechanisms including, but not limited to, adsorption, ion exchange, and chemical reaction. As the concentration of the desensitizing agents decreases in the remaining solution, untreated formation faces are exposed to aqueous fluids which promotes the deleterious chemical and physical changes.
- Current state-of-the-art implementation of desensitizing solutions call for injection of a single bolus of a relatively high concentration of desensitizing solution into the subterranean formation. Using such a method results in the depletion of desensitizing agents most notably at the leading-edge of the desensitizing solution as the solution migrates through the subterranean formation.
- the present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration; and wherein the first concentration is higher than the second concentration.
- a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid into a subterranean formation at or above the matrix pressure, wherein the leading-edge fluid comprises a first base fluid and a first desensitizing agent, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid into the subterranean formation at or above the matrix pressure, wherein the treatment fluid comprises a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration; and wherein the first concentration is higher than the second concentration.
- a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent above the matrix pressure into the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration, wherein the first concentration ranges from about 0.1% to about 15% v/v of first desensitizing agent to first base fluid; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration, wherein the second concentration ranges from about 0.001% to about 5% v/v of second desensitizing agent to second base fluid; and wherein the desensitizing solution is the same chemical composition in the leading-edge fluid and treatment fluid.
- FIG. 1 provides illustrative graphs of the concentration of the desensitizing agent within the fluid phase as a function of depth of penetration from the wellbore.
- FIG. 2 provides illustrative graphs of the concentration of the desensitizing agent at the formation faces as a function of depth of penetration from the wellbore.
- FIG. 3 provides an illustrative graph of a nonlimiting example of an injection profile of a wellbore treatment according to the present invention.
- the present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- the present invention provides for methods yielding formation face desensitization, i.e., mineral desensitization, against deleterious chemical and/or physical changes that penetrate deeper into the subterranean formation while decreasing the overall amount of the desensitizing agents. Reduction in the amount of desensitizing agents used can result in a significant cost savings for the operator and may help reduce the environmental impact of the treatment.
- penetration refers to both the distance traversed from the wellbore within a fracture network and the radially distance from the fracture into the formation, e.g., penetrating radially several clay platelets deep into the formation along a fracture.
- formation face includes the faces encountered radially from the fracture network into the formation.
- a method of desensitizing a subterranean formation may generally include the steps of: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- leading-edge fluid Because the leading-edge fluid enters the formation first, it contacts formation faces, such as water-sensitive clays, before other liquids are placed into the formation. That is, the leading-edge fluid is highly likely to encounter sensitive minerals. The depletion of desensitizing agents in the leading-edge fluids, as to contacts new formation faces, may be extensive. Therefore, a high concentration of desensitizing solution in the leading-edge fluid may effectively desensitize minerals as the fluid penetrates the subterranean formation and maintains a desensitizing solution concentration above the necessary amount to desensitize minerals deeper into the subterranean formation. The treatment fluids placed subsequent to the leading-edge fluid may exhibit lower levels of desensitizing solution than required in traditional methods.
- the treatment fluid needs not act as the primary desensitization fluid. Rather, the desensitizing agents in the treatment fluid following the leading-edge fluid may be used to desensitize any newly exposed minerals during the treatment. Therefore, the concentration of the desensitizing agents in the fracturing fluid is significantly lower than in the leading-edge fluid.
- FIGS. 1-3 compare a nonlimiting example of a treatment according to an embodiment of the present invention to current methods of injecting desensitizing agents at a constant concentration.
- FIG. 3 illustrates the injection profile, i.e., the concentration injected as a function of time.
- the leading-edge method injects first a higher concentration of destabilizing agent than a lower concentration.
- the method to which this example compares injects a single concentration over the same amount of time.
- FIGS. 1 and 2 provide a series of illustrative snapshots of what may be occurring over time in the subterranean formation as the two methods would be implemented.
- FIG. 1 looks at the concentration remaining in the fluid phase as a function of depth of penetration into the formation. It should be noted this is meant to illustrate the concentration in solution in the formation, e.g., down the length of a fracture, at a specific time point and not the injection profile. The various time points show the fluid in both treatments being depleted.
- the treatment fluid which has a significantly lower concentration, injected after the leading-edge fluid maintains the level of desensitization and therefore is not significantly depleted. Further illustrated is the level of desensitization of the formation face with a line indicating “fully” desensitized minerals.
- desensitized minerals includes substantially desensitized and most likely varies based on depth of penetration into the formation.
- the leading-edge of the fluid may not have a high enough concentration of desensitizing agents to interact with the formation faces, i.e., sensitive minerals may undergo deleterious chemical and/or physical changes at the leading-edge of a treatment.
- the methods of the present invention aim to overcome this problem by introducing a leading-edge fluid that comprises a higher concentration of desensitizing agents so that at the leading-edge of a treatment sensitive minerals are effectively desensitized.
- FIG. 2 provides the concentration injection profile at time point 3 of FIG. 1 .
- the illustrative method of the present invention uses less desensitizing agent than the method currently implemented. These figures illustrate that the methods provided herein are suited for desensitizing mineral further into a subterranean formation with the need for less overall desensitizing agent.
- compositions and methods of the present invention may be used in subterranean formations containing water-sensitive clays, tight gas formations, shales, and coal beds.
- subterranean formations may include minerals like, but not limited to, silica; iron minerals; alkaline earth metal carbonates, feldspars, biotite, illite, and chlorite; smectite clays such as montmorillonite, beidellite, nontronite, saponite hectorite and sauconite; kaolin clays such as kaolinite, nacrite, dickite, endellite and halloysite; illite clays such as hydrobiotite, glauconite and illite; chlorite clays such as chlorite, greenalite and chamosite; other clay minerals not belonging to the above groups such as vermiculite, palygorskite, sepiolite; mixed-layer (both regular and irregular) varieties of the above minerals; and
- Some suitable methods of the present invention may comprise placing a leading-edge fluid comprising a concentrated desensitizing solution into the subterranean reservoir to expose formation faces to the desensitizing agent so as to reduce, or remediate, their sensitivity to deleterious chemical and/or physical changes.
- Subsequently placed treatment fluids may comprise a lower concentration of desensitizing solution to preserve the existing level of mineral desensitization and/or inhibit sensitization of newly exposed formation faces.
- a treatment fluid introduced into a subterranean formation subsequent to a leading-edge fluid may be a fracturing fluid, an acidizing fluid, a stimulation fluid, a sand control fluid, a completion fluid, a frac-packing fluid, or gravel packing fluid.
- the methods, leading-edge fluids, and subsequent treatment fluids of the present invention may be used in full-scale operations, pills, or any combination thereof.
- a “pill” is a type of relatively small volume of specially prepared treatment fluid placed or circulated in the wellbore.
- leading-edge fluids and/or subsequent treatment fluids may be introduced at or above “fracture pressure,” which as used herein refers to pressures necessary to create or extend at least one fracture within the subterranean formation.
- leading-edge fluids and/or subsequent treatment fluids may be introduced at “matrix pressure,” which as used herein refers to pressures below the fracture pressure of the formation.
- leading-edge fluids may be introduced into a single wellbore multiple times, e.g., multi-stage fracturing operations where sections of the formation are fractured then plugged sequentially where each fracturing includes introducing a leading-edge fluid followed by at least one subsequent treatment fluid.
- a fracturing method according to the present invention may comprise multiple stages (or sections).
- the stages may include, but not be limited to, introducing a leading-edge fluid or a treatment fluid, each with the appropriate concentration of desensitizing agent, that comprise an additive that may include, but not be limited to, proppants; diverting agents including degradable diverting agents; plugs; plugging agents; and any combination thereof.
- a multi-stage treatment may include
- the stages may be defined by a perforation or a cluster of perforations.
- the diverting agent in any of the above steps may be interchanged with a plug, e.g., a packer, a bridge plug, a frac plug, or the like, or a plugging agent, e.g., perf balls, gels, plugging foams, degradable diverting agents, and the like.
- said treatment fluid may be a fracturing fluid.
- steps e.g., flushing treatments and acidizing treatments, may be included within the above nonlimiting example.
- One skilled in the art, with the benefit of this disclosure, should understand the plurality of steps that may be included and the order in which to include them to achieve a desired wellbore treatment design.
- leading-edge fluids with subsequent treatment fluids may be used in a high-rate water frac including multi-stage high-rate water fracs. These are typically done in shales that have high clay content; therefore, a leading-edge fluid with a desensitizing agent may be especially useful.
- leading-edge fluids may be used in a remedial treatment for a subterranean formation having at least some formation faces having undergone deleterious chemical and/or physical changes.
- a leading-edge fluid may be introduced into a subterranean formation for remediation at a matrix pressure so as to treat existing formation faces therein. For example, when the fractures are worn out and need to be restimulated.
- leading-edge fluids with subsequent treatment fluids may be used for injection wells.
- injection wells refer to wells in which fluids are injected rather than produced with the primary objective of maintaining reservoir pressure that may assist in production from a nearby well.
- injection wells In formations with sensitive minerals, the deleterious chemical and/or physical changes to formation faces can lead to higher injection pressures needed to maintain reservoir pressure. It is believed that employing leading edge fluids and subsequent treatment fluids, as described in some embodiments herein, could result in a lower injection pressure being required for injection wells.
- leading-edge fluids with subsequent treatment fluids may be used in a well completion operation, such as a pre-pad fluid in gravel packing operations.
- a well completion operation such as a pre-pad fluid in gravel packing operations.
- the higher concentration of desensitizing agents in a leading-edge fluid would protect the surrounding formation during the wellbore completion operations.
- the optimal concentration of desensitizing agents to use in the leading-edge fluid can be determined by one skilled in the art.
- One suitable method for determining the optimal concentration of desensitizing agents to be used in the leading-edge fluid involves a four-step analysis. First, determine the total mineral concentration(s) and mineral type(s) from known methods including, but not limited to, x-ray analysis and scanning electron microscopy. Second, determine the desensitizing capacity of a formation sample. By way of non-limiting example, the cation exchange capacity of a formation sample can be determined by Langmuir adsorption isotherms, surface roughness, and cation exchange capacity. Third, estimate the generated surface area during the fracture treatment using known simulation methods. Finally, estimate the mass of desensitizing agents required using the values determined in the first three steps.
- An approximate concentration of desensitizing agents to use in the leading-edge fluid can be determined by one skilled in the arts by generally characterizing the degree to which the mineral(s) in the subterranean formation require desensitization.
- water-sensitive clays may be categorized as very water sensitive, moderately water sensitive, or minimally water sensitive.
- one skilled in the arts may be able to estimate the necessary desensitization of the minerals in the subterranean formation based on known characteristics of the formation, nearby wells, and similar formations.
- a preferred method for desensitizing minerals calls for the concentration of the desensitizing agents in the leading-edge fluid to range from a lower limit of about 0.01%, 0.05%, 0.1%, 0.5%, 1%, 2%, 5%, or 10% to an upper limit of about 60%, 50%, 25%, 15%, 10%, or 5% v/v, and wherein the concentration may range from any lower limit to any upper limit and encompass any subset therebetween. Minerals requiring more desensitization may require more concentrated desensitizing solution in the leading-edge fluid relative to the fracturing fluid.
- a preferred method for desensitizing minerals calls for the concentration of the desensitizing agents in subsequent treatment fluids to range from a lower limit of about 0.0001%, 0.001%, 0.01%, 0.1%, or 1% to an upper limit of about 20%, 10%, 5%, 2%, 1%, or 0.1% v/v, where the concentration may range from any lower limit to any upper limit and encompass any subset therebetween.
- the concentration of desensitizing agents in the leading-edge fluid may range from a lower limit of about 2, 3, 5, 10, or 25 times to an upper limit of about 5000, 2500, 1000, 500, 100, 75, 50, or 25 times greater than the concentration of desensitizing agents in the treatment fluid, and wherein the concentration may range from any lower limit to any upper limit and encompass any subset therebetween.
- the concentration of desensitizing agents may vary during the fracturing operation, i.e., during the introduction of the fracturing fluid.
- the concentration change may be step-wise, gradient, or any combination thereof.
- a transition fluid may be used between the leading-edge fluid and subsequent treatment fluids.
- the transition fluid may comprise desensitizing agents at an intermediate concentration relative to the leading-edge fluid and subsequent treatment fluids.
- a transition fluid may provide for a step-wise, gradient, or combination thereof concentration reduction of the desensitizing agents from the leading-edge fluid to the subsequent treatment fluids.
- the transition fluid may be introduced to the subterranean formation at a matrix pressure, at or above formation pressure, or any combination thereof.
- the concentration of desensitizing agents in leading-edge fluids, transition fluids, and/or subsequent treatment fluids may be adjusted on-the-fly.
- the fluid being introduced into the wellbore may be changed based on a pressure change observed at the surface of the wellbore.
- a pressure drop at the surface of a wellbore may indicated fracturing is occurring and a transition to a leading-edge fluid is necessary.
- desensitizing agents suitable for use in subterranean operations may be used in the methods of the present invention including, but not limited to, inorganic acids, salts, polyelectrolytes, multivalent ions, inorganic bases, strong bases, oxides, resins, surfactants, polymers, cationic polymers, methyl glucosides, polyglycerols, polyglycols, emulsion facilitating particles, chelating agents, phosphines, soluble organic stabilizing compounds, silica control agents, embrittlement modification agents, surface modification agents, microparticles, nanoparticles, and any combination thereof.
- the desensitizing agents may be the same or different chemical compositions within the various fluids for use in the methods provided herein.
- the leading-edge fluid may comprise an expensive desensitizing agent that is more effective at desensitizing formation faces. Subsequent fluids may be less expensive desensitizing agents that maintain the level of desensitization at the formation faces.
- the desensitizing agents may be for desensitizing a single mineral composition or multiple mineral compositions, e.g., desensitizing water-swellable clays and shales in a single treatment fluid. When more than one desensitizing agent is used, the desensitizing agents can be at the same or different concentrations relative to one another within the various fluids for use in the methods provided herein.
- the preparation of a desensitizing solution is expected to be according to a preferred preparation embodiment for the desensitizing solution, which is known by one skilled in the arts.
- the desensitizing agents may be in various forms: foams, latexes, microemulsions, emulsions, simple solutions, surfactants, nanoparticles, microparticles, degradable particulates, dry form that later breaks up, gelled form, and combinations thereof.
- Desensitizing agents may interact with the surfaces, interlayers, and cores of minerals and mineral platelets to mitigate or reverse mineral hydration, swelling, and sloughing.
- Charges on the minerals and mineral platelets may permit interaction with dissolved/suspended molecules and ions in fluids, both native and non-native to the formation.
- the net negative charge on a platelet may be typically balanced mainly by cationic molecules and ions, e.g., sodium ions and silicates.
- the cations, or charge-balancing ions, associated with the platelet faces are termed “exchangeable” as they can be readily substituted with other cations when presented to the clay platelets.
- Each macroscopic mineral particle may be comprised of many thousands of sandwiched mineral platelets, each having exchangeable cations and a layer of water therebetween.
- water may penetrate between the platelets, forcing them further apart.
- the cations present at the platelet faces may begin to diffuse away from platelet faces.
- the amount of water contained within the platelets may be dependant upon the pressure under which the mineral is located, typically the depth of the mineral deposit in the subterranean formation.
- Mechanisms of mineral hydration may include surface hydration through bonding of water molecules to oxygen atoms on the surface of mineral platelets; ionic hydration through hydration of interlayer cations with surrounding shells of water molecules; and osmotic hydration, which occurs in some minerals after they are completely surface hydrated and ionically hydrated, usually at 100% humidity.
- Suitable desensitizing agents may include, but not be limited to, salts, resins, soluble organic stabilizing compounds, silica control agents, embrittlement modification agents, and any combination thereof.
- inorganic acids, organic acids, salts thereof, and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention including, but not limited to, inorganic acids, salts of inorganic acids, organic acids, salts of organic acids, or any combination thereof.
- a “salt” of an acid, as that term is used herein, refers to any compound that shares the same base formula as the referenced acid, but one of the hydrogen cations thereon is replaced by a different cation (e.g., an antimony, bismuth, potassium, sodium, calcium, magnesium, cesium, zinc cation).
- Suitable inorganic salts may include cations of Group I and II elements.
- inorganic acid refers to any acidic compound that does not comprise a carbon atom.
- suitable salts of inorganic acids include, but are not limited to, sodium chloride, calcium chloride, potassium chloride, sodium bromide, calcium bromide, potassium bromide, sodium sulfate, calcium sulfate, sodium phosphate, calcium phosphate, sodium nitrate, calcium nitrate, cesium chloride, cesium sulfate, cesium phosphate, cesium nitrate, cesium bromide, potassium sulfate, potassium phosphate, potassium nitrate, zinc chloride, magnesium chloride, magnesium bromide, zinc bromide, and the like.
- Suitable salts may be Group I and II salts.
- organic acid refers to any acidic compound that comprises a carbon atom.
- suitable salts of organic acids include, but are not limited to, sodium acetate, sodium formate, calcium acetate, calcium formate, cesium acetate, cesium formate, potassium acetate, potassium formate, magnesium acetate, magnesium formate, zinc acetate, zinc formate, antimony acetate, antimony formate, bismuth acetate, and bismuth formate.
- Suitable inorganic acids may include, but not be limited to, hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, boric acid, and the like, or any combination thereof.
- Suitable organic acids may include, but not be limited to, acetic acid, formic acid, citric acid, oxalic acid, and the like, or any combination thereof.
- the various fluids for use in the methods provided herein may comprise any combination of inorganic acids, salts of inorganic acids, organic acids, and/or salts of organic acids.
- the one or more inorganic acids and/or organic acids (or salts thereof) may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the inorganic acid(s) and/or organic acid(s) (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular acid and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- inorganic bases organic bases, strong bases, and combinations thereof known in the art suitable for use in subterranean operations may be used in the methods of the present invention.
- Suitable inorganic bases may include, but not be limited to, sodium hydroxide, ammonium hydroxide, barium hydroxide, calcium hydroxide, magnesium hydroxide, potassium hydroxide, sodium carbonate, ammonium carbonate, barium carbonate, calcium carbonate, magnesium carbonate, potassium carbonate, magnesium chloride triethylamine, sodium amide, and the like, or any combinations thereof.
- Suitable organic bases may include, but not be limited to, pyridine, methyl amine, imidazole, benzimidazole, histidine, phophazene, dimethylaniline, trimethylamine, piperidine, and the like, or any combination thereof.
- Suitable strong bases may include, but not be limited to, sodium hydroxide, potassium hydroxide, calcium hydroxide, barium hydroxide, and the like, or any combination thereof.
- the various fluids for use in the methods provided herein may comprise any combination of inorganic bases, organic bases, and strong bases.
- the one or more inorganic bases, organic bases, and strong bases may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the inorganic bases, organic bases, and strong bases included in the various fluids for use in the methods provided herein may depend upon the particular base used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- any polymer or resin known in the art that is suitable for use in subterranean operations may be used in the methods of the present invention, including salts thereof.
- cationic polymer may be preferred, e.g., amines and imines.
- the polymers and resins can be synthetic or natural and non-hardenable or hardenable.
- Polymers and resins suitable for use in the present invention include all polymers, resins, and combinations thereof known in the art that desensitize clay.
- polymers and resins suitable for use in the present invention include, but are not limited to: acrylic acid polymers; partially hydrolyzed polyacrylamide (PHA); acrylic acid ester polymers; acrylic acid derivative polymers; acrylic acid homopolymers; acrylic acid ester homopolymers (such as poly(methyl acrylate), poly(butyl acrylate), and poly(2-ethylhexyl acrylate)); acrylic acid ester co-polymers; methacrylic acid derivative polymers; methacrylic acid homopolymers; methacrylic acid ester homopolymers (such as poly(methyl methacrylate), poly(butyl methacrylate), and poly(2-ethylhexyl methacrylate)); acrylamido-methyl-propane sulfonate polymers; acrylamido-methyl-propane sulfonate derivative polymers; acrylamido-methyl-propane sulfonate co-polymers; acrylic acid/acrylamido-methyl-
- the polymers or resins (or salts thereof) and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the polymer or resin (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular polymer, resin, and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Suitable surfactants and combinations thereof for use in the present invention may include anionic surfactants, cationic surfactants, amphoteric surfactants, and/or nonionic surfactants.
- surfactants that may be suitable for use in the present invention include, but are not limited to C 12 to C 22 alkyl phosphonate surfactants, ethoxylated nonyl phenol phosphate esters, ethoxylated fatty acids, sodium dodecyl sulfate, poly(vinyl alcohol), sodium dodecylbenzenesulfonic acid, cetyltrimethylammonium bromide, cetylpyridinium bromide, hexadecylmaltoside, trimethylcocoammonium chloride, trimethyltallowammonium chloride, dimethyldicocoammonium chloride, bis(2-hydroxyethyl)tallowamine, bis(2-hydroxyethyl)erucylamine, erucyl methyl bis(2-hydroxyethy
- 19NTM surfactant a cationic nonemulsifier, available from Halliburton Energy Services, Inc.
- TWEEN® surfactants a polysorbate surfactant, available from Sigma-Aldrich
- TRITON® surfactants a nonionic surfactant, available from Sigma-Aldrich
- BRIJ® surfactants a nonionic surfactant, available from Sigma-Aldrich
- Certain cationic surfactants may be incompatible or undesirable to use with certain anionic polymers, minerals present on the mineral surface, and/or other elements or conditions in a treatment fluid (e.g., pH) and/or subterranean formation present in a particular application of the present invention.
- a treatment fluid e.g., pH
- subterranean formation present in a particular application of the present invention.
- the surfactants (or salts thereof) and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the surfactant (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular surfactant and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- particulates may comprise emulsion facilitating particles, i.e., any particle with a size smaller than a discontinuous phase droplet in the emulsion.
- the emulsion facilitating particles have a size less than about 75 microns. Generally, smaller emulsion facilitating particles are preferred.
- Suitable examples of emulsion facilitating particles include particles that have or exhibit a suitable fluid contact angle, such as any organically modified material, metal sulfate, or polymer. Suitable organically modified materials may include modified silicas, modified fumed silicas, or various clay types.
- Fumed silicas may have slightly different degrees of organic modification when small amounts of dimethyldichlorosilane are added in the process of fuming the silica.
- suitable modified silicas or modified fumed silicas include, but not be limited to, HDK® silicas (silica silylates, Wacker-Chemie GmbH) such as HDK® H20, HDK® H30, and HDK® H2000.
- the HDK® silicas are loose white powders that are primarily amorphous lattice structures of SiO 2 .
- Suitable organically modified materials also may include organically modified aluminum, titanium, zirconium, or various clay types.
- Various clay types may include non-kaolinitic clays such as bentonite, kaolin clays, and any other clay types capable of cation exchange.
- the emulsion facilitating particles and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the emulsion facilitating particles included in the various fluids for use in the methods provided herein may depend upon the particular emulsion facilitating particles used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Suitable organic acids include, but are not limited to, formic acid, acetic acid, citric acid, glycolic acid, lactic acid, 3-hydroxypropionic acid, a C 1 to C 12 carboxylic acid, an aminopolycarboxylic acid such as hydroxyethylethylenediamine triacetic acid, and combinations thereof.
- the various fluids for use in the methods provided herein may comprise a salt of an organic acid.
- a “salt” of an acid refers to any compound that shares the same base formula as the referenced acid, but one of the hydrogen cations thereon is replaced by a different cation (e.g., an antimony, bismuth, potassium, sodium, calcium, magnesium, cesium, or zinc cation).
- suitable salts of organic acids include, but are not limited to, sodium acetate, sodium formate, calcium acetate, calcium formate, cesium acetate, cesium formate, potassium acetate, potassium formate, magnesium acetate, magnesium formate, zinc acetate, zinc formate, antimony acetate, antimony formate, bismuth acetate, and bismuth formate.
- the one or more organic acids (or salts thereof) may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the organic acid(s) (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular acid and/or salt used, as well as other components of the treatment fluid, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- a variety of monomers (or salts thereof) are suitable for use as an organic stabilizing compound in the present invention.
- suitable monomers include, but are not limited to, acrylic acid, methacrylic acid, acrylamide, methacrylamide, 2-methacrylamido-2-methylpropane sulfonic acid, dimethylacrylamide, vinyl sulfonic acid, N,N-dimethylaminoethylmethacrylate, 2-triethylammoniumethylmethacrylate chloride, N,N-dimethyl-aminopropylmethacryl-amide, methacrylamidepropyltriethylammonium chloride, N-vinyl pyrrolidone, quaternary amines, imidazolium salts, phosphonium salts, vinyl-phosphonic acid, methacryloyloxyethyl trimethylammonium sulfate, 1-carboxy-N,N,N-trimethyl methanaminium chloride, 2-hydroxy-N,N
- the organic stabilizing compounds and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the organic stabilizing compounds included in the various fluids for use in the methods provided herein may depend upon the particular organic stabilizing compounds used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Suitable chelating agents may comprise amines, esters, carboxylic acids, alcohols, ethers, aldehydes, ketones, mercaptans, thiols, and/or combinations thereof.
- chelating agents include ethylenediaminetetraacetic acid (“EDTA”), nitrilotriacetic acid (“NTA”), hydroxyethylethylenediaminetriacetic acid (“HEDTA”), dicarboxymethyl glutamic acid tetrasodium salt (“GLDA”), diethylenetriaminepentaacetic acid (“DTPA”), propylenediaminetetraacetic acid (“PDTA”), ethylenediaminedi(o-hydroxyphenylacetic) acid (“EDDHA”), glucoheptonic acid, gluconic acid, amino tri(methylene phosphonic acid), penta sodium salt of aminotri(methylene phosphonic acid), tetra sodium salt of aminotri(methylene phosphonic acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, hexamethylenediamine tetra(methylene phosphonic acid), diethylenetriamine penta(methylene phosphonic acid), bis(hexamethylene triamine penta
- the chelating agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the chelating agents included in the various fluids for use in the methods provided herein may depend upon the particular chelating agents used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- silica control agents and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention. Without limiting the invention to a particular theory or mechanism of action, it is nevertheless currently believed that silica may act as a binder of clay, sand, diageneous minerals, clasts, and/or other fine particulates in subterranean formations.
- the silica control agent may comprise a compound chosen from the group consisting of: silica, silicates (e.g., orthosilicates, pyrosilicates, cyclic-silicates, single chain silicates, double chain silicates, sheet silicates, colloidal silicates), silanes, organo-silanes, and any combination thereof.
- silicates e.g., orthosilicates, pyrosilicates, cyclic-silicates, single chain silicates, double chain silicates, sheet silicates, colloidal silicates
- silanes e.g., silica control agent
- organo-silanes e.g., colloidal silicates
- Suitable examples of naturally occurring minerals comprising silica or a silicate include, but are not limited to, phenacite, willemite, zircon, olivine, garnet, thortveitite, benitoite, beryl, pyroxenes, enstatite, spodumene, pollucite, tremolite, crocidolite, talc, petalite, cristobalite, and any combination thereof.
- phenacite willemite, zircon, olivine, garnet, thortveitite, benitoite, beryl, pyroxenes, enstatite, spodumene, pollucite, tremolite, crocidolite, talc, petalite, cristobalite, and any combination thereof.
- finely ground refers to mesh sizes smaller than or equal to 270 U.S.
- Suitable silicates include, but are not limited to, potassium silicate, calcium silicate, sodium aluminum silicate, and sodium silicate.
- Suitable commercially available silica control agents may include INJECTROL® (a sealant, available from Halliburton Energy Services, Inc). However, dilution to near the saturation point may be required for such products to be suitable silica control agents in order to avoid precipitation and plugging of the formation.
- non-polymeric metal silicates such as sodium silicate or potassium silicate
- the silicate may be sodium silicate having a weight ratio of SiO 2 to Na 2 O ranging from about 3.25:1 to 1.5:1.
- the silicate may be potassium silicate having a ratio of SiO 2 to K 2 O ranging from about 2.5:1 to 1.5:1.
- Silanes may include chemicals that contain silicone at the center of the silane molecule that is chemically attached to a first functional group such as vinyl, amino, chloro, epoxy, mercapto, and a second functional group such as methoxy or ethoxy.
- suitable silanes and organo-silanes may include, but not be limited to, N2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, n-beta-(aminoethyl)-gamma-aminopropyl trimethoxysilane, methyltrimethoxysilane, vinyltrimethoxysilane, methyltriethoxysilane, tetraethoxysilane, methyltriacetoxysilane, methyl tris-(N-methylbenzamidosilane), methyl tris-(methyl ethyl ketoximino)silane, methyl tris
- the silica control agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the silica control agents included in the various fluids for use in the methods provided herein may depend upon the particular silica control agent used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- embrittlement and its derivatives as used herein refers to a process by which the properties of a material are changed through a chemical interaction such that a material that originally behaves in a ductile or plastic manner is transformed to a material that behaves in a more brittle manner. This may be determined by examining the Young's modulus and the Poisson's ratio of the natural rock before treatment. If the rock has become embrittled, the Young's modulus should be higher and the Poisson's ratio should be lower as compared to the natural rock before treatment.
- Young's modulus is the ratio of stress, which has units of pressure, to strain, which is dimensionless; therefore Young's modulus itself has units of pressure.
- the SI unit of modulus of elasticity (E, or less commonly Y) is the pascal (Pa or N/m 2 ); the practical units are megapascals (MPa or N/mm 2 ) or gigapascals (GPa or kN/mm 2 ). In United States customary units, it is expressed as pounds (force) per square inch (psi).
- Young's modulus, E can be calculated by dividing the tensile stress by the tensile strain:
- E is the Young's modulus (modulus of elasticity).
- F is the force applied to the object
- a o is the original cross-sectional area through which the force is applied
- ⁇ L is the amount by which the length of the object changes
- L 0 is the original length of the object.
- Poisson's ratio (v) is the ratio, when a sample object is stretched, of the contraction or transverse strain (perpendicular to the applied load), to the extension or axial strain (in the direction of the applied load).
- ⁇ trans is transverse strain (negative for axial tension, positive for axial compression).
- ⁇ axial is axial strain (positive for axial tension, negative for axial compression).
- Suitable embrittlement modification agents for use in the present invention may comprise high alkaline materials. Suitable examples may include, but not be limited to, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, cesium hydroxide, sodium carbonate, sodium silicate, lime, amines, ammonia, borates, Lewis bases, other strong bases, and any derivative or combination thereof.
- concentration of the embrittlement modification agent in a treatment fluid may depend on the desired pH (e.g., about 10 or above at downhole conditions) of the fluid given the factors involved in the treatment.
- the embrittlement modification agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect.
- the amount of the embrittlement modification agents included in the various fluids for use in the methods provided herein may depend upon the particular embrittlement modification agent used, as well as other components of the treatment fluid, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- embrittlement modification agents for use in the present invention may comprise cationic additives, such as cationic polymers and cationic organic additives, to enhance the plasticity modification.
- Divalent cationic additives may be more stable. If used, such cationic additives may be used in an amount of about 0.01% to about 1% by weight of the embrittlement modification agents. Hydroxy aluminum and zirconium oxychloride are examples.
- CLA-STA® XP CLA-STA® FS
- CLAYFIX® an acid salt, available from Halliburton Energy Services, Inc.
- CLAYFIX®-II a temporary clay stabilizing additive, available from Halliburton Energy Services, Inc.
- CLAYFIX®-II PLUS a temporary clay stabilizing additive, available from Halliburton Energy Services, Inc.
- HPT-1TM a cationic polymer, available from Halliburton Energy Services, Inc.
- Suitable additives are described in the following patents, each of which are hereby incorporated by reference, U.S. Pat. Nos. 5,097,094, 4,974,678, 4,424,076, and 4,366,071.
- embrittlement modification agents for use in the present invention may comprise salt(s) such as salts of lithium, sodium, potassium, rubidium, calcium, strontium, barium, cesium, magnesium, and manganese.
- salts such as salts of lithium, sodium, potassium, rubidium, calcium, strontium, barium, cesium, magnesium, and manganese.
- the ion exchange resulting from the presence of the salt is useful in aiding in the shrinkage of the rock.
- including surfactants in the embrittlement modification agents may facilitate ultra low surface tensions and allow these fluids to penetrate into a subterranean formation more easily, e.g., via microfractures and between mineral platelets.
- microparticles refers to particles less than 500 microns in one dimension, but larger than nanoparticles.
- nanoparticles refers to particles with at least one dimension less than about 100 nm.
- microparticles and combinations thereof known in the art that are suitable for use in subterranean operations and can adsorb and/or bind to minerals may be used in the methods of the present invention.
- suitable microparticles may include, but not be limited to, metal oxide microparticles like silica, titania, alumina, magnesium oxide, calcium oxide, and the like; minerals like slag, zeolite, vitrified shale, silica flour, silica sand; polymeric microparticles including those that comprise the polymers and/or resins disclosed herein; or any combination thereof.
- Nanoparticles and combinations thereof known in the art that are suitable for use in subterranean operations and can adsorb and/or bind to minerals may be used in the methods of the present invention.
- suitable nanoparticles may include, but not be limited to, carbon nanoparticles like fullerenes (spherical or otherwise), endofullerenes, nanotubes (single or multi-walled), filled nanotubes, carbon nanohorns, carbon nano-bamboo, graphene (single to few layer thick), and carbon quantum dots; metal oxide nanoparticles like silica, titania, alumina, iron oxide, manganese oxide, zinc oxide, molybdenum oxide, magnesium oxide, and calcium oxide; metal nanoparticles like gold, palladium, silver, and palladium; nitride nanoparticles; carbide nanoparticles; magnetic nanoparticles like Fe 3 O 4 and gamma-Fe 2 O 3 ; quantum dots like CdSe and ZnS; any
- nanoparticles include nanorods, nanospheres, nanorices, nanowires, nanostars (like nanotripods and nanotetrapods), hollow nanostructures, hybrid nanostructures that are two or more nanoparticles connected as one, and non-nano particles with nano-coatings or nano-thick walls.
- nanoparticles include the functionalized derivatives of nanoparticles including, but not limited to, nanoparticles that have been functionalized covalently and/or non-covalently, e.g., pi-stacking, physisorption, ionic association, van der Waals association, and the like.
- Suitable functional groups may include, but not be limited to, moieties comprising amines (1°, 2°, or 3°), amides, carboxylic acids, aldehydes, ketones, ethers, esters, peroxides, silyls, organosilanes, hydrocarbons, aromatic hydrocarbons, and any combination thereof; polymers; chelating agents like ethylenediamine tetraacetate, diethylenetriaminepentaacetic acid, triglycollamic acid, and a structure comprising a pyrrole ring; and any combination thereof.
- Proppants suitable for use in the present invention may comprise any material suitable for use in subterranean operations. Suitable materials for these proppants include, but are not limited to, sand, bauxite, ceramic materials, glass materials, polymer materials, polytetrafluoroethylene materials, nut shell pieces, cured resinous particulates comprising nut shell pieces, seed shell pieces, cured resinous particulates comprising seed shell pieces, fruit pit pieces, cured resinous particulates comprising fruit pit pieces, wood, composite particulates, and combinations thereof.
- Suitable composite particulates may comprise a binder and a filler material wherein suitable filler materials include silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly ash, hollow glass microspheres, solid glass, and combinations thereof.
- suitable filler materials include silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly ash, hollow glass microspheres, solid glass, and combinations thereof.
- the mean particulate size generally may range from about 2 mesh to about 400 mesh on the U.S. Sieve Series; however, in certain circumstances, other mean particulate sizes may be desired and will be entirely suitable for practice of the present invention.
- preferred mean particulates size distribution ranges are one or more of 6/12, 8/16, 12/20, 16/30, 20/40, 30/50, 40/60, 40/70, or 50/70 mesh.
- the term “particulate,” as used in this disclosure includes all known shapes of materials, including substantially spherical materials, fibrous materials, polygonal materials (such as cubic materials), and combinations thereof.
- fibrous materials that may or may not be used to bear the pressure of a closed fracture, may be included in certain embodiments of the present invention.
- the proppant may be present in the various fluids described herein in an amount in the range of from about 0.5 pounds per gallon (“ppg”) to about 30 ppg by volume of the treatment fluid, and encompass any subset therebetween.
- the base fluid of a leading-edge fluid, transition fluid, and/or treatment fluid may comprise oil-based fluids, aqueous-based fluids, aqueous-miscible fluids, water-in-oil emulsions, or oil-in-water emulsions.
- Suitable oil-based fluids may include alkanes, olefins, aromatic organic compounds, cyclic alkanes, paraffins, diesel fluids, mineral oils, desulfurized hydrogenated kerosenes, and any combination thereof.
- Suitable aqueous-based fluids may include fresh water, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated salt water), seawater, and any combination thereof.
- the water may be from any source, provided that it does not contain components that might adversely affect the stability and/or performance of the leading-edge fluid or the fracturing fluid of the present invention.
- the density of the aqueous base fluid can be adjusted, among other purposes, to provide additional particulate transport and suspension in the leading-edge fluid or the fracturing fluid used in the methods of the present invention.
- the pH of the aqueous base fluid may be adjusted (e.g., by a buffer or other pH adjusting agent), among other purposes, to reduce the viscosity of the leading-edge fluid or fracturing fluid.
- the pH may be adjusted to a specific level, which may depend on, among other factors, the types of gelling agents, acids, and other additives included in the leading-edge fluid or fracturing fluid.
- Suitable aqueous-miscible fluids may include, but not be limited to, alcohols, e.g., methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, and t-butanol; glycerins; glycols, e.g., polyglycols, propylene glycol, and ethylene glycol; polyglycol amines; polyols; any derivative thereof; any in combination with salts, e.g., sodium chloride, calcium chloride, calcium bromide, zinc bromide, potassium carbonate, sodium formate, potassium formate, cesium formate, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, ammonium chloride, ammonium bromide, sodium nitrate, potassium nitrate, ammonium nitrate, ammonium sulfate, calcium nitrate,
- Suitable water-in-oil emulsions also known as invert emulsions, may have an oil-to-water ratio from a lower limit of greater than about 50:50, 55:45, 60:40, 65:35, 70:30, 75:25, or 80:20 to an upper limit of less than about 100:0, 95:5, 90:10, 85:15, 80:20, 75:25, 70:30, or 65:35 by volume in the base treatment fluid, and wherein the amount may range from any lower limit to any upper limit and encompass any subset therebetween.
- suitable invert emulsions include those disclosed in U.S. Pat. No. 5,905,061, U.S. Pat. No. 5,977,031, and U.S. Pat. No.
- the base fluid may be foamed, i.e., may comprise a foaming agent and a gas.
- Suitable foaming agents may be any known foaming agent that does not cause deleterious chemical and/or physical changes to the formation faces and may be used in a sufficient amount to achieve a desired foam, which should be known to one skilled in the art.
- the gas is selected from the group consisting of nitrogen, carbon dioxide, air, methane, helium, argon, and any combination thereof.
- the quality of the foamed fracturing fluid may range from a lower limit of about 5%, 10%, 25%, 40%, 50%, 60%, or 70% gas volume to an upper limit of about 99%, 90%, 80%, 75%, 60%, or 50% gas volume, and wherein the quality of the foamed fracturing fluid may range from any lower limit to any upper limit and encompass any subset therebetween.
- the various fluids described herein can further comprise additives including, but not limited to, salts, weighting agents, inert solids, fluid loss control agents, emulsifiers, dispersion aids, corrosion inhibitors, emulsion thinners, emulsion thickeners, viscosifying agents, high-pressure and high-temperature emulsifier-filtration control agents, surfactants, particulates, proppants, lost circulation materials, foaming agents, gases, pH control additives, breakers, biocides, crosslinkers, stabilizers, scale inhibitors, mutual solvents, oxidizers, reducers, friction reducers, and any combination thereof.
- additives including, but not limited to, salts, weighting agents, inert solids, fluid loss control agents, emulsifiers, dispersion aids, corrosion inhibitors, emulsion thinners, emulsion thickeners, viscosifying agents, high-pressure and high-temperature emulsifier-filtration control agents, surfactants, particulates
- a method of desensitizing a subterranean formation may generally include the steps of: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- a method of remedially desensitizing a subterranean formation may generally include the steps of: providing a wellbore penetrating a subterranean formation that comprises a plurality of formation faces, the formation faces having undergone deleterious chemical and/or physical changes; introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- a method of desensitizing a subterranean formation may generally include the steps of: providing a wellbore penetrating a subterranean formation; introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into a first portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into the first portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration; then diverting fluid flow from the first portion of the subterranean formation to a second portion of the subterranean formation; then introducing a second leading-edge fluid comprising a third base fluid and a third desensitizing agent into the second portion of the subterranean formation, where
- Table 1 For a well located in Saudi, X-ray diffraction analysis (Table 1) indicates only trace amounts of smectite clay in the obtained shale samples with a significant amount of mixed layers which may contain swelling clays.
- a decrease in permeability of brine after exposure to fresh water comparing with brine pressure after treatment of 1% CLA-WEBTM clay-stabilization additive solution indicates that this 1% CLA-WEBTM clay-stabilization additive concentration was not sufficient for clay protection, which will result in permeability reduction.
- the treatment with 3% CLA-WEBTM clay-stabilization additive solution indicates this CLA-WEBTM clay-stabilization additive concentration was more appropriate to minimize any potential of permeability damage.
- compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. All numbers and ranges disclosed above may vary by some amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values.
Abstract
A method of desensitizing a subterranean formation may include introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
Description
- The present application is a continuation-in-part of U.S. patent application Ser. No. 13/106,382 filed on May 12, 2011, the entire disclosure of which is incorporated herein by reference.
- The present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- The recovery of fluids such as oil and gas from subterranean formations has been troublesome in formations that contain sensitive minerals capable of undergoing chemical and physical changes along the formation faces, e.g., minerals that swell, slough, degrade, release fines, or become ductile. As used herein, “formation faces” refers to any portion of the formation that is exposed to, for example, a treatment fluid, and includes fracture faces and platelet faces. As used herein, “ductile” refers to becoming able to deform under pressure.
- Often these troublesome formations undergo chemical and physical changes when exposed to aqueous fluids, a common base for subterranean treatment fluids. Troublesome formations may include, but not be limited to, water-sensitive clays, tight gas formations, shales, and coal beds. The terms “clays” and “water-sensitive clays” are used herein interchangeably to generally indicate water-sensitive clays that, when contacted by aqueous fluids in disequilibrium with the minerals in the formation, tend to swell and/or migrate. The clay content of the formations may be a single species of a clay mineral or several species, including, but not limited to, the mixed-layer types of clay. As used herein, the term “tight gas” refers to gas found in sedimentary rock that is cemented together so that permeabilities are relatively low. As used herein, the term “shale” refers to a sedimentary rock formed from the consolidation of fine clay and silt materials into laminated, thin bedding planes. As used herein, “coal bed” refers to a rock formation that may be comprised of, inter alia, one or more types of coal, including, but not limited to, peat, lignite, sub-bituminous coal, bituminous coal, anthracite, and graphite.
- The chemical and physical changes in the formation faces often results in the blockage and/or closure of passageways that penetrate the subterranean formation (e.g., fracture network, pore throats, etc.), thereby causing a loss in permeability of the formation. This loss in permeability impairs the flow of fluid through the wellbore and, in some cases, may even completely block the flow of fluids through portions of the formation. Loss in permeability often leads to a decrease in the production for the well. Moreover, some changes in the formation faces, e.g., migrating fines, can be produced with the formation fluids, thereby presenting potential abrasion and other problems with the production equipment and potential reduction in fracture conductivity.
- In an effort to overcome these problems, various methods have been developed for treating problematic formations to desensitize the formation faces from chemical and physical changes. For example, it has been common practice to add salts to aqueous drilling fluids. The salts adsorb to the clay surfaces in an ion exchange process that can reduce the swelling and/or migration of the clays. Another method used to deter migration is to coat the region with a polymer and/or a consolidating resin in order to physically block the migration of the clays. The term “desensitizing solution” as used herein refers to any solution or suspension used to reduce the sensitivity of minerals within a subterranean formation to chemical and physical changes. The terms “desensitizing components” and “desensitizing agents” as used herein refer to the components of a desensitizing solution that interacts with formation faces to reduce the sensitivity of minerals to chemical and physical changes.
- When a desensitizing solution is exposed to formation faces of problematic formations, the desensitizing agents are removed from the desensitizing solution by the formation faces through known mechanisms including, but not limited to, adsorption, ion exchange, and chemical reaction. As the concentration of the desensitizing agents decreases in the remaining solution, untreated formation faces are exposed to aqueous fluids which promotes the deleterious chemical and physical changes. Current state-of-the-art implementation of desensitizing solutions call for injection of a single bolus of a relatively high concentration of desensitizing solution into the subterranean formation. Using such a method results in the depletion of desensitizing agents most notably at the leading-edge of the desensitizing solution as the solution migrates through the subterranean formation.
- The present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- In some embodiments of the present invention, a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration; and wherein the first concentration is higher than the second concentration.
- In some embodiments of the present invention, a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid into a subterranean formation at or above the matrix pressure, wherein the leading-edge fluid comprises a first base fluid and a first desensitizing agent, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid into the subterranean formation at or above the matrix pressure, wherein the treatment fluid comprises a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration; and wherein the first concentration is higher than the second concentration.
- In some embodiments of the present invention, a method of desensitizing a subterranean formation may comprise: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent above the matrix pressure into the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration, wherein the first concentration ranges from about 0.1% to about 15% v/v of first desensitizing agent to first base fluid; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent, wherein the second desensitizing agent is present in the second base fluid at a second concentration, wherein the second concentration ranges from about 0.001% to about 5% v/v of second desensitizing agent to second base fluid; and wherein the desensitizing solution is the same chemical composition in the leading-edge fluid and treatment fluid.
- The features and advantages of the present invention will be readily apparent to those skilled in the art upon a reading of the description of the preferred embodiments that follows.
- The following figures are included to illustrate certain aspects of the present invention, and should not be viewed as exclusive embodiments. The subject matter disclosed is capable of considerable modification, alteration, and equivalents in form and function, as will occur to those skilled in the art and having the benefit of this disclosure.
-
FIG. 1 provides illustrative graphs of the concentration of the desensitizing agent within the fluid phase as a function of depth of penetration from the wellbore. -
FIG. 2 provides illustrative graphs of the concentration of the desensitizing agent at the formation faces as a function of depth of penetration from the wellbore. -
FIG. 3 provides an illustrative graph of a nonlimiting example of an injection profile of a wellbore treatment according to the present invention. - The present invention relates to multi-stage methods for treating a subterranean formation in order to desensitize formation faces to deleterious chemical or physical changes.
- Of the many advantages, the present invention provides for methods yielding formation face desensitization, i.e., mineral desensitization, against deleterious chemical and/or physical changes that penetrate deeper into the subterranean formation while decreasing the overall amount of the desensitizing agents. Reduction in the amount of desensitizing agents used can result in a significant cost savings for the operator and may help reduce the environmental impact of the treatment. It should be noted that the term “penetration” refers to both the distance traversed from the wellbore within a fracture network and the radially distance from the fracture into the formation, e.g., penetrating radially several clay platelets deep into the formation along a fracture. It should be noted that the term “formation face” includes the faces encountered radially from the fracture network into the formation.
- In some embodiments, a method of desensitizing a subterranean formation may generally include the steps of: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- Because the leading-edge fluid enters the formation first, it contacts formation faces, such as water-sensitive clays, before other liquids are placed into the formation. That is, the leading-edge fluid is highly likely to encounter sensitive minerals. The depletion of desensitizing agents in the leading-edge fluids, as to contacts new formation faces, may be extensive. Therefore, a high concentration of desensitizing solution in the leading-edge fluid may effectively desensitize minerals as the fluid penetrates the subterranean formation and maintains a desensitizing solution concentration above the necessary amount to desensitize minerals deeper into the subterranean formation. The treatment fluids placed subsequent to the leading-edge fluid may exhibit lower levels of desensitizing solution than required in traditional methods. Because the leading-edge fluid has been placed before the treatment fluid, so long as the interval to be treated by the treatment fluid has been fully contacted by the leading-edge fluid, the treatment fluid needs not act as the primary desensitization fluid. Rather, the desensitizing agents in the treatment fluid following the leading-edge fluid may be used to desensitize any newly exposed minerals during the treatment. Therefore, the concentration of the desensitizing agents in the fracturing fluid is significantly lower than in the leading-edge fluid.
-
FIGS. 1-3 compare a nonlimiting example of a treatment according to an embodiment of the present invention to current methods of injecting desensitizing agents at a constant concentration.FIG. 3 illustrates the injection profile, i.e., the concentration injected as a function of time. In this nonlimiting example, the leading-edge method injects first a higher concentration of destabilizing agent than a lower concentration. The method to which this example compares injects a single concentration over the same amount of time.FIGS. 1 and 2 provide a series of illustrative snapshots of what may be occurring over time in the subterranean formation as the two methods would be implemented. -
FIG. 1 looks at the concentration remaining in the fluid phase as a function of depth of penetration into the formation. It should be noted this is meant to illustrate the concentration in solution in the formation, e.g., down the length of a fracture, at a specific time point and not the injection profile. The various time points show the fluid in both treatments being depleted. In the leading-edge fluid method illustrated, the treatment fluid, which has a significantly lower concentration, injected after the leading-edge fluid maintains the level of desensitization and therefore is not significantly depleted. Further illustrated is the level of desensitization of the formation face with a line indicating “fully” desensitized minerals. One skilled in the art, with the benefit of this disclosure, should understand “fully” desensitized minerals includes substantially desensitized and most likely varies based on depth of penetration into the formation. In this example, it is only used to illustrate the point that as desensitizing agents are depleted from the fluid, the leading-edge of the fluid may not have a high enough concentration of desensitizing agents to interact with the formation faces, i.e., sensitive minerals may undergo deleterious chemical and/or physical changes at the leading-edge of a treatment. In some embodiments, the methods of the present invention aim to overcome this problem by introducing a leading-edge fluid that comprises a higher concentration of desensitizing agents so that at the leading-edge of a treatment sensitive minerals are effectively desensitized. - Further,
FIG. 2 provides the concentration injection profile attime point 3 ofFIG. 1 . The illustrative method of the present invention uses less desensitizing agent than the method currently implemented. These figures illustrate that the methods provided herein are suited for desensitizing mineral further into a subterranean formation with the need for less overall desensitizing agent. - The compositions and methods of the present invention may be used in subterranean formations containing water-sensitive clays, tight gas formations, shales, and coal beds. Specifically, subterranean formations may include minerals like, but not limited to, silica; iron minerals; alkaline earth metal carbonates, feldspars, biotite, illite, and chlorite; smectite clays such as montmorillonite, beidellite, nontronite, saponite hectorite and sauconite; kaolin clays such as kaolinite, nacrite, dickite, endellite and halloysite; illite clays such as hydrobiotite, glauconite and illite; chlorite clays such as chlorite, greenalite and chamosite; other clay minerals not belonging to the above groups such as vermiculite, palygorskite, sepiolite; mixed-layer (both regular and irregular) varieties of the above minerals; and any combination thereof.
- Some suitable methods of the present invention may comprise placing a leading-edge fluid comprising a concentrated desensitizing solution into the subterranean reservoir to expose formation faces to the desensitizing agent so as to reduce, or remediate, their sensitivity to deleterious chemical and/or physical changes. Subsequently placed treatment fluids may comprise a lower concentration of desensitizing solution to preserve the existing level of mineral desensitization and/or inhibit sensitization of newly exposed formation faces.
- As used herein, the term “treatment,” or “treating,” refers to any subterranean operation that uses a fluid in conjunction with a desired function and/or for a desired purpose. The term “treatment,” or “treating,” does not imply any particular action by the fluid. By way of nonlimiting examples, a treatment fluid introduced into a subterranean formation subsequent to a leading-edge fluid may be a fracturing fluid, an acidizing fluid, a stimulation fluid, a sand control fluid, a completion fluid, a frac-packing fluid, or gravel packing fluid. The methods, leading-edge fluids, and subsequent treatment fluids of the present invention may be used in full-scale operations, pills, or any combination thereof. As used herein, a “pill” is a type of relatively small volume of specially prepared treatment fluid placed or circulated in the wellbore.
- In some embodiments, leading-edge fluids and/or subsequent treatment fluids may be introduced at or above “fracture pressure,” which as used herein refers to pressures necessary to create or extend at least one fracture within the subterranean formation. In some embodiments, leading-edge fluids and/or subsequent treatment fluids may be introduced at “matrix pressure,” which as used herein refers to pressures below the fracture pressure of the formation.
- In some embodiments, leading-edge fluids may be introduced into a single wellbore multiple times, e.g., multi-stage fracturing operations where sections of the formation are fractured then plugged sequentially where each fracturing includes introducing a leading-edge fluid followed by at least one subsequent treatment fluid.
- In some embodiments, a fracturing method according to the present invention may comprise multiple stages (or sections). The stages may include, but not be limited to, introducing a leading-edge fluid or a treatment fluid, each with the appropriate concentration of desensitizing agent, that comprise an additive that may include, but not be limited to, proppants; diverting agents including degradable diverting agents; plugs; plugging agents; and any combination thereof. By way of nonlimiting example, a multi-stage treatment may include
-
- (a) introducing a first leading-edge fluid comprising a first concentration of a desensitizing agent into a first stage of a wellbore penetrating a subterranean formation, the first leading-edge fluid optionally comprising a proppant;
- (b) introducing a first treatment fluid comprising a second concentration of desensitizing agent that is lower than the first concentration into the first stage of the wellbore, the first treatment fluid optionally comprising a proppant;
- (c) introducing a second treatment fluid comprising a diverting agent to substantially divert subsequent fluids from the first stage of the wellbore, the second treatment fluid optionally comprising a desensitizing agent and/or a proppant;
- (d) introducing a second leading-edge fluid comprising a third concentration of a desensitizing agent into a second stage of a wellbore penetrating a subterranean formation, the second leading-edge fluid optionally comprising a proppant;
- (e) introducing a third treatment fluid comprising a fourth concentration of desensitizing agent that is lower than the third concentration into the second stage of the wellbore, the third treatment fluid optionally comprising a proppant;
- (f) introducing a fourth treatment fluid comprising a diverting agent to substantially divert subsequent fluids from the second stage of the wellbore, the fourth treatment fluid optionally comprising a desensitizing agent and/or a proppant; and
- (g) continuing until several stages, e.g., 50 or more, are treated.
- In some embodiments, the stages may be defined by a perforation or a cluster of perforations. It should be noted that the diverting agent in any of the above steps may be interchanged with a plug, e.g., a packer, a bridge plug, a frac plug, or the like, or a plugging agent, e.g., perf balls, gels, plugging foams, degradable diverting agents, and the like. Also, said treatment fluid may be a fracturing fluid. Further, it should be noted that other steps, e.g., flushing treatments and acidizing treatments, may be included within the above nonlimiting example. One skilled in the art, with the benefit of this disclosure, should understand the plurality of steps that may be included and the order in which to include them to achieve a desired wellbore treatment design.
- In some embodiments, leading-edge fluids with subsequent treatment fluids may be used in a high-rate water frac including multi-stage high-rate water fracs. These are typically done in shales that have high clay content; therefore, a leading-edge fluid with a desensitizing agent may be especially useful.
- In some embodiments, leading-edge fluids may be used in a remedial treatment for a subterranean formation having at least some formation faces having undergone deleterious chemical and/or physical changes. By way of nonlimiting example, a leading-edge fluid may be introduced into a subterranean formation for remediation at a matrix pressure so as to treat existing formation faces therein. For example, when the fractures are worn out and need to be restimulated.
- In some embodiments, leading-edge fluids with subsequent treatment fluids may be used for injection wells. As used herein, “injection wells” refer to wells in which fluids are injected rather than produced with the primary objective of maintaining reservoir pressure that may assist in production from a nearby well. In formations with sensitive minerals, the deleterious chemical and/or physical changes to formation faces can lead to higher injection pressures needed to maintain reservoir pressure. It is believed that employing leading edge fluids and subsequent treatment fluids, as described in some embodiments herein, could result in a lower injection pressure being required for injection wells.
- In some embodiments, leading-edge fluids with subsequent treatment fluids may be used in a well completion operation, such as a pre-pad fluid in gravel packing operations. The higher concentration of desensitizing agents in a leading-edge fluid would protect the surrounding formation during the wellbore completion operations.
- The optimal concentration of desensitizing agents to use in the leading-edge fluid can be determined by one skilled in the art. One suitable method for determining the optimal concentration of desensitizing agents to be used in the leading-edge fluid involves a four-step analysis. First, determine the total mineral concentration(s) and mineral type(s) from known methods including, but not limited to, x-ray analysis and scanning electron microscopy. Second, determine the desensitizing capacity of a formation sample. By way of non-limiting example, the cation exchange capacity of a formation sample can be determined by Langmuir adsorption isotherms, surface roughness, and cation exchange capacity. Third, estimate the generated surface area during the fracture treatment using known simulation methods. Finally, estimate the mass of desensitizing agents required using the values determined in the first three steps.
- An approximate concentration of desensitizing agents to use in the leading-edge fluid can be determined by one skilled in the arts by generally characterizing the degree to which the mineral(s) in the subterranean formation require desensitization. By way of non-limiting example, water-sensitive clays may be categorized as very water sensitive, moderately water sensitive, or minimally water sensitive. Additionally, one skilled in the arts may be able to estimate the necessary desensitization of the minerals in the subterranean formation based on known characteristics of the formation, nearby wells, and similar formations.
- It should be noted that when “about” is provided at the beginning of a numerical list, “about” modifies each number of the numerical list. It should be noted that in some numerical listings of ranges, some lower limits listed may be greater than some upper limits listed. One skilled in the art will recognize that the selected subset will require the selection of an upper limit in excess of the selected lower limit.
- A preferred method for desensitizing minerals calls for the concentration of the desensitizing agents in the leading-edge fluid to range from a lower limit of about 0.01%, 0.05%, 0.1%, 0.5%, 1%, 2%, 5%, or 10% to an upper limit of about 60%, 50%, 25%, 15%, 10%, or 5% v/v, and wherein the concentration may range from any lower limit to any upper limit and encompass any subset therebetween. Minerals requiring more desensitization may require more concentrated desensitizing solution in the leading-edge fluid relative to the fracturing fluid.
- A preferred method for desensitizing minerals calls for the concentration of the desensitizing agents in subsequent treatment fluids to range from a lower limit of about 0.0001%, 0.001%, 0.01%, 0.1%, or 1% to an upper limit of about 20%, 10%, 5%, 2%, 1%, or 0.1% v/v, where the concentration may range from any lower limit to any upper limit and encompass any subset therebetween. In some embodiments, the concentration of desensitizing agents in the leading-edge fluid may range from a lower limit of about 2, 3, 5, 10, or 25 times to an upper limit of about 5000, 2500, 1000, 500, 100, 75, 50, or 25 times greater than the concentration of desensitizing agents in the treatment fluid, and wherein the concentration may range from any lower limit to any upper limit and encompass any subset therebetween. In some embodiments, the concentration of desensitizing agents may vary during the fracturing operation, i.e., during the introduction of the fracturing fluid. In some embodiments, the concentration change may be step-wise, gradient, or any combination thereof.
- In some embodiments, a transition fluid may be used between the leading-edge fluid and subsequent treatment fluids. The transition fluid may comprise desensitizing agents at an intermediate concentration relative to the leading-edge fluid and subsequent treatment fluids. In some embodiments, a transition fluid may provide for a step-wise, gradient, or combination thereof concentration reduction of the desensitizing agents from the leading-edge fluid to the subsequent treatment fluids. In some embodiments, the transition fluid may be introduced to the subterranean formation at a matrix pressure, at or above formation pressure, or any combination thereof.
- In some embodiments, the concentration of desensitizing agents in leading-edge fluids, transition fluids, and/or subsequent treatment fluids may be adjusted on-the-fly. In some embodiments, the fluid being introduced into the wellbore may be changed based on a pressure change observed at the surface of the wellbore. By way of nonlimiting example, a pressure drop at the surface of a wellbore may indicated fracturing is occurring and a transition to a leading-edge fluid is necessary.
- Nearly all desensitizing agents suitable for use in subterranean operations may be used in the methods of the present invention including, but not limited to, inorganic acids, salts, polyelectrolytes, multivalent ions, inorganic bases, strong bases, oxides, resins, surfactants, polymers, cationic polymers, methyl glucosides, polyglycerols, polyglycols, emulsion facilitating particles, chelating agents, phosphines, soluble organic stabilizing compounds, silica control agents, embrittlement modification agents, surface modification agents, microparticles, nanoparticles, and any combination thereof. The desensitizing agents may be the same or different chemical compositions within the various fluids for use in the methods provided herein. Utilizing different chemical compositions may be advantageous to further reduce costs. By way of nonlimiting example, the leading-edge fluid may comprise an expensive desensitizing agent that is more effective at desensitizing formation faces. Subsequent fluids may be less expensive desensitizing agents that maintain the level of desensitization at the formation faces. Further, the desensitizing agents may be for desensitizing a single mineral composition or multiple mineral compositions, e.g., desensitizing water-swellable clays and shales in a single treatment fluid. When more than one desensitizing agent is used, the desensitizing agents can be at the same or different concentrations relative to one another within the various fluids for use in the methods provided herein. The preparation of a desensitizing solution is expected to be according to a preferred preparation embodiment for the desensitizing solution, which is known by one skilled in the arts. The desensitizing agents may be in various forms: foams, latexes, microemulsions, emulsions, simple solutions, surfactants, nanoparticles, microparticles, degradable particulates, dry form that later breaks up, gelled form, and combinations thereof.
- Examples of suitable desensitizing agents and mechanisms of desensitization may be found in the following documents, all of which are incorporated herein by referenced: U.S. Pat. Nos. 7,740,071; 5,197,544; and 4,366,073, U.S. Patent Publication No. 2004/0235667, and U.S. patent application Ser. Nos. 13/113,533 (filed May 23, 2011 and titled “Silica Control Agents for Use in Subterranean Treatment Fluids”); 12/751,770 (filed May 31, 2010 and titled “Methods for Strengthening Fractures in Subterranean Formations”); 12/826,426 (filed Jun. 29, 2010 and titled “Methods Relating to Improved Stimulation Treatments and Strengthening Fractures in Subterranean Formations”; and 12/851,953 (filed Aug. 6, 2010 and titled “Methods for Strengthening Fractures in Subterranean Formations”).
- Desensitizing agents may interact with the surfaces, interlayers, and cores of minerals and mineral platelets to mitigate or reverse mineral hydration, swelling, and sloughing. Charges on the minerals and mineral platelets may permit interaction with dissolved/suspended molecules and ions in fluids, both native and non-native to the formation. The net negative charge on a platelet may be typically balanced mainly by cationic molecules and ions, e.g., sodium ions and silicates. The cations, or charge-balancing ions, associated with the platelet faces are termed “exchangeable” as they can be readily substituted with other cations when presented to the clay platelets. Each macroscopic mineral particle may be comprised of many thousands of sandwiched mineral platelets, each having exchangeable cations and a layer of water therebetween. When the mineral and water are mixed, water may penetrate between the platelets, forcing them further apart. The cations present at the platelet faces may begin to diffuse away from platelet faces. Further, the amount of water contained within the platelets may be dependant upon the pressure under which the mineral is located, typically the depth of the mineral deposit in the subterranean formation. Mechanisms of mineral hydration may include surface hydration through bonding of water molecules to oxygen atoms on the surface of mineral platelets; ionic hydration through hydration of interlayer cations with surrounding shells of water molecules; and osmotic hydration, which occurs in some minerals after they are completely surface hydrated and ionically hydrated, usually at 100% humidity. Suitable desensitizing agents may include, but not be limited to, salts, resins, soluble organic stabilizing compounds, silica control agents, embrittlement modification agents, and any combination thereof.
- Nearly all inorganic acids, organic acids, salts thereof, and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention including, but not limited to, inorganic acids, salts of inorganic acids, organic acids, salts of organic acids, or any combination thereof. A “salt” of an acid, as that term is used herein, refers to any compound that shares the same base formula as the referenced acid, but one of the hydrogen cations thereon is replaced by a different cation (e.g., an antimony, bismuth, potassium, sodium, calcium, magnesium, cesium, zinc cation). Suitable inorganic salts may include cations of Group I and II elements. The term “inorganic acid” refers to any acidic compound that does not comprise a carbon atom. Examples of suitable salts of inorganic acids include, but are not limited to, sodium chloride, calcium chloride, potassium chloride, sodium bromide, calcium bromide, potassium bromide, sodium sulfate, calcium sulfate, sodium phosphate, calcium phosphate, sodium nitrate, calcium nitrate, cesium chloride, cesium sulfate, cesium phosphate, cesium nitrate, cesium bromide, potassium sulfate, potassium phosphate, potassium nitrate, zinc chloride, magnesium chloride, magnesium bromide, zinc bromide, and the like. Suitable salts may be Group I and II salts. The term “organic acid” refers to any acidic compound that comprises a carbon atom. Examples of suitable salts of organic acids include, but are not limited to, sodium acetate, sodium formate, calcium acetate, calcium formate, cesium acetate, cesium formate, potassium acetate, potassium formate, magnesium acetate, magnesium formate, zinc acetate, zinc formate, antimony acetate, antimony formate, bismuth acetate, and bismuth formate.
- Suitable inorganic acids may include, but not be limited to, hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, boric acid, and the like, or any combination thereof. Suitable organic acids may include, but not be limited to, acetic acid, formic acid, citric acid, oxalic acid, and the like, or any combination thereof.
- When included, the various fluids for use in the methods provided herein may comprise any combination of inorganic acids, salts of inorganic acids, organic acids, and/or salts of organic acids. The one or more inorganic acids and/or organic acids (or salts thereof) may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the inorganic acid(s) and/or organic acid(s) (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular acid and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Inorganic bases, organic bases, strong bases, and combinations thereof known in the art suitable for use in subterranean operations may be used in the methods of the present invention. Suitable inorganic bases may include, but not be limited to, sodium hydroxide, ammonium hydroxide, barium hydroxide, calcium hydroxide, magnesium hydroxide, potassium hydroxide, sodium carbonate, ammonium carbonate, barium carbonate, calcium carbonate, magnesium carbonate, potassium carbonate, magnesium chloride triethylamine, sodium amide, and the like, or any combinations thereof. Suitable organic bases may include, but not be limited to, pyridine, methyl amine, imidazole, benzimidazole, histidine, phophazene, dimethylaniline, trimethylamine, piperidine, and the like, or any combination thereof. Suitable strong bases may include, but not be limited to, sodium hydroxide, potassium hydroxide, calcium hydroxide, barium hydroxide, and the like, or any combination thereof.
- When included, the various fluids for use in the methods provided herein may comprise any combination of inorganic bases, organic bases, and strong bases. The one or more inorganic bases, organic bases, and strong bases may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the inorganic bases, organic bases, and strong bases included in the various fluids for use in the methods provided herein may depend upon the particular base used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- To the extent they are useful as desensitizing agents, any polymer or resin known in the art that is suitable for use in subterranean operations may be used in the methods of the present invention, including salts thereof. Of these, cationic polymer may be preferred, e.g., amines and imines. The polymers and resins can be synthetic or natural and non-hardenable or hardenable. Polymers and resins suitable for use in the present invention include all polymers, resins, and combinations thereof known in the art that desensitize clay. Examples of polymers and resins suitable for use in the present invention include, but are not limited to: acrylic acid polymers; partially hydrolyzed polyacrylamide (PHA); acrylic acid ester polymers; acrylic acid derivative polymers; acrylic acid homopolymers; acrylic acid ester homopolymers (such as poly(methyl acrylate), poly(butyl acrylate), and poly(2-ethylhexyl acrylate)); acrylic acid ester co-polymers; methacrylic acid derivative polymers; methacrylic acid homopolymers; methacrylic acid ester homopolymers (such as poly(methyl methacrylate), poly(butyl methacrylate), and poly(2-ethylhexyl methacrylate)); acrylamido-methyl-propane sulfonate polymers; acrylamido-methyl-propane sulfonate derivative polymers; acrylamido-methyl-propane sulfonate co-polymers; acrylic acid/acrylamido-methyl-propane sulfonate co-polymers; bisphenol A diglycidyl ether resins; butoxymethyl butyl glycidyl ether resins; bisphenol A-epichlorohydrin resins; bisphenol F resins; polyepoxide resins; novolak resins; polyester resins; phenol-aldehyde resins; urea-aldehyde resins; furan resins; urethane resins; glycidyl ether resins; other epoxide resins; polyacrylamide; partially hydrolyzed polyacrylamide; copolymers of acrylamide and acrylate; carboxylate-containing terpolymers; tetrapolymers of acrylate; galactose; mannose; glucoside; glucose; xylose; arabinose; fructose; glucuronic acid; pyranosyl sulfate; guar gum; locust bean gum; tara; konjak; tamarind; starch; cellulose; karaya; xanthan; tragacanth; carrageenan; polycarboxylates such as polyacrylates and polymethacrylates; polyacrylamides; methylvinyl ether polymers; polyvinyl alcohols; polyvinylpyrrolidone; polyalkylene imines (such as polyethylene imine and polypropylene imine); polyamines (such as putrescine, cadaverine, spermidine, spermine, diethylenetriamine, tetramethylenediamine, trimethylenetetramine, tetraethylenepentamine, polyethylene amine, cyclen); organo-polyamines; quaternized polyamines; CLA-STA® XP (a water-soluble cationic oligomer, available from Halliburton Energy Services, Inc.); CLA-STA® FS (a mineral stabilizing polymer, available from Halliburton Energy Services, Inc.); and CLA-WEB™ (a stabilizing additive, available from Halliburton Energy Services, Inc); derivatives thereof; salts thereof; and combinations thereof.
- The polymers or resins (or salts thereof) and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the polymer or resin (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular polymer, resin, and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Suitable surfactants and combinations thereof for use in the present invention may include anionic surfactants, cationic surfactants, amphoteric surfactants, and/or nonionic surfactants. Examples of surfactants that may be suitable for use in the present invention include, but are not limited to C12 to C22 alkyl phosphonate surfactants, ethoxylated nonyl phenol phosphate esters, ethoxylated fatty acids, sodium dodecyl sulfate, poly(vinyl alcohol), sodium dodecylbenzenesulfonic acid, cetyltrimethylammonium bromide, cetylpyridinium bromide, hexadecylmaltoside, trimethylcocoammonium chloride, trimethyltallowammonium chloride, dimethyldicocoammonium chloride, bis(2-hydroxyethyl)tallowamine, bis(2-hydroxyethyl)erucylamine, erucyl methyl bis(2-hydroxyethyl)ammonium chloride, bis(2-hydroxyethyl)coco-amine, cetylpyridinium chloride, N,N,N,trimethyl-1-octadecamonium chloride, fatty amine salts, polyamines, ammonium salts, quaternary ammonium compounds (e.g., alkyl quaternary ammonium salts), alkyl pyridinium salts, and any derivatives thereof. An example of commercially-available surfactants that may be suitable in certain embodiments of the present invention is 19N™ surfactant (a cationic nonemulsifier, available from Halliburton Energy Services, Inc.), TWEEN® surfactants (a polysorbate surfactant, available from Sigma-Aldrich), TRITON® surfactants (a nonionic surfactant, available from Sigma-Aldrich), and BRIJ® surfactants (a nonionic surfactant, available from Sigma-Aldrich). Certain cationic surfactants may be incompatible or undesirable to use with certain anionic polymers, minerals present on the mineral surface, and/or other elements or conditions in a treatment fluid (e.g., pH) and/or subterranean formation present in a particular application of the present invention. One of skill in the art, with the benefit of this disclosure, should be able to select a cationic surfactant that is compatible with these elements.
- The surfactants (or salts thereof) and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the surfactant (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular surfactant and/or salt thereof used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- In some embodiments, particulates may comprise emulsion facilitating particles, i.e., any particle with a size smaller than a discontinuous phase droplet in the emulsion. In some exemplary embodiments, the emulsion facilitating particles have a size less than about 75 microns. Generally, smaller emulsion facilitating particles are preferred. Suitable examples of emulsion facilitating particles include particles that have or exhibit a suitable fluid contact angle, such as any organically modified material, metal sulfate, or polymer. Suitable organically modified materials may include modified silicas, modified fumed silicas, or various clay types. Fumed silicas may have slightly different degrees of organic modification when small amounts of dimethyldichlorosilane are added in the process of fuming the silica. Examples of suitable modified silicas or modified fumed silicas include, but not be limited to, HDK® silicas (silica silylates, Wacker-Chemie GmbH) such as HDK® H20, HDK® H30, and HDK® H2000. The HDK® silicas are loose white powders that are primarily amorphous lattice structures of SiO2. Suitable organically modified materials also may include organically modified aluminum, titanium, zirconium, or various clay types. Various clay types may include non-kaolinitic clays such as bentonite, kaolin clays, and any other clay types capable of cation exchange.
- The emulsion facilitating particles and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the emulsion facilitating particles included in the various fluids for use in the methods provided herein may depend upon the particular emulsion facilitating particles used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Nearly all organic stabilizing compounds and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention.
- Examples of suitable organic acids include, but are not limited to, formic acid, acetic acid, citric acid, glycolic acid, lactic acid, 3-hydroxypropionic acid, a C1 to C12 carboxylic acid, an aminopolycarboxylic acid such as hydroxyethylethylenediamine triacetic acid, and combinations thereof. Alternatively or in combination with the one or more organic acids, the various fluids for use in the methods provided herein may comprise a salt of an organic acid. A “salt” of an acid, as that term is used herein, refers to any compound that shares the same base formula as the referenced acid, but one of the hydrogen cations thereon is replaced by a different cation (e.g., an antimony, bismuth, potassium, sodium, calcium, magnesium, cesium, or zinc cation). Examples of suitable salts of organic acids include, but are not limited to, sodium acetate, sodium formate, calcium acetate, calcium formate, cesium acetate, cesium formate, potassium acetate, potassium formate, magnesium acetate, magnesium formate, zinc acetate, zinc formate, antimony acetate, antimony formate, bismuth acetate, and bismuth formate. The one or more organic acids (or salts thereof) may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the organic acid(s) (or salts thereof) included in the various fluids for use in the methods provided herein may depend upon the particular acid and/or salt used, as well as other components of the treatment fluid, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- A variety of monomers (or salts thereof) are suitable for use as an organic stabilizing compound in the present invention. Examples of suitable monomers include, but are not limited to, acrylic acid, methacrylic acid, acrylamide, methacrylamide, 2-methacrylamido-2-methylpropane sulfonic acid, dimethylacrylamide, vinyl sulfonic acid, N,N-dimethylaminoethylmethacrylate, 2-triethylammoniumethylmethacrylate chloride, N,N-dimethyl-aminopropylmethacryl-amide, methacrylamidepropyltriethylammonium chloride, N-vinyl pyrrolidone, quaternary amines, imidazolium salts, phosphonium salts, vinyl-phosphonic acid, methacryloyloxyethyl trimethylammonium sulfate, 1-carboxy-N,N,N-trimethyl methanaminium chloride, 2-hydroxy-N,N,N-trimethyl ethanaminium acetate, 2-hydroxy-N,N,N-trimethyl 1-propanaminium acetate, tetra alkyl ammonium, bis-(hydrogenated tallow)-dimethyl-ammonium chloride, bis-(hydrogenated tallow)-benzyl-methyl-ammonium chloride, 4,5-dihydro-1-methyl-2-nortallow-alkyl-1-(2-tallow-amidoethyl)-imidazolium methyl sulfate, 1-ethyl-4,5-dihydro-3-(2-hydroxyethyl)-2-(8-heptadecenyl)-imidazolium ethyl sulfate, putrescine, cadaverine, spermidine, spermine, diethylenetriamine, tetramethylenediamine, trimethylenetetramine, tetraethylenepentamine, and any combination thereof.
- The organic stabilizing compounds and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the organic stabilizing compounds included in the various fluids for use in the methods provided herein may depend upon the particular organic stabilizing compounds used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Nearly all chelating agents and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention. Suitable chelating agents may comprise amines, esters, carboxylic acids, alcohols, ethers, aldehydes, ketones, mercaptans, thiols, and/or combinations thereof. Examples of suitable chelating agents include ethylenediaminetetraacetic acid (“EDTA”), nitrilotriacetic acid (“NTA”), hydroxyethylethylenediaminetriacetic acid (“HEDTA”), dicarboxymethyl glutamic acid tetrasodium salt (“GLDA”), diethylenetriaminepentaacetic acid (“DTPA”), propylenediaminetetraacetic acid (“PDTA”), ethylenediaminedi(o-hydroxyphenylacetic) acid (“EDDHA”), glucoheptonic acid, gluconic acid, amino tri(methylene phosphonic acid), penta sodium salt of aminotri(methylene phosphonic acid), tetra sodium salt of aminotri(methylene phosphonic acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, hexamethylenediamine tetra(methylene phosphonic acid), diethylenetriamine penta(methylene phosphonic acid), bis(hexamethylene triamine penta(methylene phosphonic acid)), 2-phosphonobutane-1,2,4-tricarboxylic acid, monoethanloamine diphosphonate, etidronic acid, potassium salts of (1-hydroxyethylidene)diphosphonic acid, tetrasodium (1-hydroxyethylidene)biphosphonate, sodium salts of (1-hydroxyethylidene)diphosphonic acid, disodium salts of hydroxyethylidene 1,1-diphosphonic acid, sodium salts of diethylene triamine penta(methylene phosphonic acid), sodium salts of bis hexamethylene triamine penta(methylene phosphonic acid), sodium salts of 2-phosphonobutane-1,2,4-tricarboxylic acid, tetrasodium etidronate, maleic acid, polymers of modified polyacrylic acid, sulphonated polyacrylic acid, carboxymethyl inulin, any salt thereof, any derivative thereof, and any combination thereof.
- The chelating agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the chelating agents included in the various fluids for use in the methods provided herein may depend upon the particular chelating agents used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Nearly all silica control agents and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention. Without limiting the invention to a particular theory or mechanism of action, it is nevertheless currently believed that silica may act as a binder of clay, sand, diageneous minerals, clasts, and/or other fine particulates in subterranean formations.
- In some embodiments, the silica control agent may comprise a compound chosen from the group consisting of: silica, silicates (e.g., orthosilicates, pyrosilicates, cyclic-silicates, single chain silicates, double chain silicates, sheet silicates, colloidal silicates), silanes, organo-silanes, and any combination thereof. In some embodiments, the silica control agent may be provided by a natural mineral comprising silica or a silicate. Suitable examples of naturally occurring minerals comprising silica or a silicate include, but are not limited to, phenacite, willemite, zircon, olivine, garnet, thortveitite, benitoite, beryl, pyroxenes, enstatite, spodumene, pollucite, tremolite, crocidolite, talc, petalite, cristobalite, and any combination thereof. One skilled in the art will recognize that in order to be able to use naturally occurring silicates they would need to be finely ground in order to be sufficiently soluble/suspendable. As used herein, the term “finely ground” refers to mesh sizes smaller than or equal to 270 U.S. Mesh (53 microns), 325 U.S. Mesh (44 microns), 400 U.S. Mesh (37 microns), 550 U.S. Mesh (25 microns), 800 U.S. Mesh (15 microns), or 1250 U.S. Mesh (10 microns). Other suitable silicates include, but are not limited to, potassium silicate, calcium silicate, sodium aluminum silicate, and sodium silicate. Suitable commercially available silica control agents may include INJECTROL® (a sealant, available from Halliburton Energy Services, Inc). However, dilution to near the saturation point may be required for such products to be suitable silica control agents in order to avoid precipitation and plugging of the formation. In some preferred embodiments non-polymeric metal silicates, such as sodium silicate or potassium silicate, may be preferred. In some preferred embodiments, the silicate may be sodium silicate having a weight ratio of SiO2 to Na2O ranging from about 3.25:1 to 1.5:1. In some preferred embodiments, the silicate may be potassium silicate having a ratio of SiO2 to K2O ranging from about 2.5:1 to 1.5:1.
- Silanes may include chemicals that contain silicone at the center of the silane molecule that is chemically attached to a first functional group such as vinyl, amino, chloro, epoxy, mercapto, and a second functional group such as methoxy or ethoxy. Examples of suitable silanes and organo-silanes may include, but not be limited to, N2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, n-beta-(aminoethyl)-gamma-aminopropyl trimethoxysilane, methyltrimethoxysilane, vinyltrimethoxysilane, methyltriethoxysilane, tetraethoxysilane, methyltriacetoxysilane, methyl tris-(N-methylbenzamidosilane), methyl tris-(methyl ethyl ketoximino)silane, methyl tris-(methylisobutylketoximino)silane, methyl vinyl bis-(methyl ethylketoximino) silane, tetrakis-(methyl ethylketoximino)silane, methyl tris-(isprenoxy)silane, methyl tris-(cyclohexylamino)silane, gamma-aminopropyltriethoxysilane, N-beta-(aminoethyl)-gamma-aminopropyltrimethoxysilanes, aminoethyl-N-beta-(aminoethyl)-gamma-aminopropyl-trimethoxysilanes, gamma-ureidopropyl-triethoxysilanes, beta-(3-4 epoxy-cyclohexyl)-ethyl-trimethoxysilane, gamma-glycidoxypropyltrimethoxysilanes, vinyltrichlorosilane, vinyltris(beta-methoxyethoxy)silane, vinyltriethoxysilane, vinyltrimethoxysilane, 3-metacryloxypropyltrimethoxysilane, beta-(3,4 epoxycyclohexyl)-ethyltrimethoxysilane, r-glycidoxypropyltrimethoxysilane, r-glycidoxypropylmethylidiethoxysilane, N-B(aminoethyl)-raminopropyl-trimethoxysilane, N-beta(aminoethyl)-raminopropylmethyldimethoxysilane, 3-aminopropyl-triethoxysilane, N-phenyl-r-aminopropyltrimethoxysilane, r-mercaptopropyltrimethoxysilane, vinyltrichlorosilane, vinyltris(β-methoxyethoxy)silane, vinyltrimethoxysilane, r-metacryloxypropyltrimethoxysilane, beta-(3,4 epoxycyclohexyl)-ethyltrimethoxysilane, r-glycidoxypropyltrimethoxysilane, r-glycidoxypropylmethylidiethoxysilane, N-beta(aminoethyl)-r-aminopropyltrimethoxysilane, N-beta(aminoethyl)-r-aminopropylmethyldimethoxysilane, r-aminopropyltriethoxysilane, N-phenyl-raminopropyltrimethoxysilane, r-mercaptopropyltrimethoxysilane, and any derivative thereof, and any combination thereof.
- The silica control agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the silica control agents included in the various fluids for use in the methods provided herein may depend upon the particular silica control agent used, as well as other components of the various fluids, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Nearly all embrittlement modification agents and combinations thereof known in the art that are suitable for use in subterranean operations may be used in the methods of the present invention. The term “embrittlement” and its derivatives as used herein refers to a process by which the properties of a material are changed through a chemical interaction such that a material that originally behaves in a ductile or plastic manner is transformed to a material that behaves in a more brittle manner. This may be determined by examining the Young's modulus and the Poisson's ratio of the natural rock before treatment. If the rock has become embrittled, the Young's modulus should be higher and the Poisson's ratio should be lower as compared to the natural rock before treatment.
- Young's modulus is the ratio of stress, which has units of pressure, to strain, which is dimensionless; therefore Young's modulus itself has units of pressure. The SI unit of modulus of elasticity (E, or less commonly Y) is the pascal (Pa or N/m2); the practical units are megapascals (MPa or N/mm2) or gigapascals (GPa or kN/mm2). In United States customary units, it is expressed as pounds (force) per square inch (psi). Young's modulus, E, can be calculated by dividing the tensile stress by the tensile strain:
-
- Where:
- E is the Young's modulus (modulus of elasticity);
- F is the force applied to the object;
- Ao is the original cross-sectional area through which the force is applied;
- ΔL is the amount by which the length of the object changes; and
- L0 is the original length of the object.
- Poisson's ratio (v) is the ratio, when a sample object is stretched, of the contraction or transverse strain (perpendicular to the applied load), to the extension or axial strain (in the direction of the applied load).
-
- Where:
- v is the resulting Poisson's ratio,
- εtrans is transverse strain (negative for axial tension, positive for axial compression); and
- εaxial is axial strain (positive for axial tension, negative for axial compression).
- Suitable embrittlement modification agents for use in the present invention may comprise high alkaline materials. Suitable examples may include, but not be limited to, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, cesium hydroxide, sodium carbonate, sodium silicate, lime, amines, ammonia, borates, Lewis bases, other strong bases, and any derivative or combination thereof. The concentration of the embrittlement modification agent in a treatment fluid may depend on the desired pH (e.g., about 10 or above at downhole conditions) of the fluid given the factors involved in the treatment.
- The embrittlement modification agents and combinations thereof may be present in the various fluids for use in the methods provided herein in an amount sufficient to provide the desired effect. The amount of the embrittlement modification agents included in the various fluids for use in the methods provided herein may depend upon the particular embrittlement modification agent used, as well as other components of the treatment fluid, and/or other factors that will be recognized by one of ordinary skill in the art with the benefit of this disclosure.
- Optionally, embrittlement modification agents for use in the present invention may comprise cationic additives, such as cationic polymers and cationic organic additives, to enhance the plasticity modification. Divalent cationic additives may be more stable. If used, such cationic additives may be used in an amount of about 0.01% to about 1% by weight of the embrittlement modification agents. Hydroxy aluminum and zirconium oxychloride are examples. Other examples may include, but not be limited to, CLA-STA® XP, CLA-STA® FS, CLAYFIX® (an acid salt, available from Halliburton Energy Services, Inc.), CLAYFIX®-II (a temporary clay stabilizing additive, available from Halliburton Energy Services, Inc.), and CLAYFIX®-II PLUS (a temporary clay stabilizing additive, available from Halliburton Energy Services, Inc.), HPT-1™ (a cationic polymer, available from Halliburton Energy Services, Inc.), and combinations thereof. Suitable additives are described in the following patents, each of which are hereby incorporated by reference, U.S. Pat. Nos. 5,097,094, 4,974,678, 4,424,076, and 4,366,071.
- Optionally, embrittlement modification agents for use in the present invention may comprise salt(s) such as salts of lithium, sodium, potassium, rubidium, calcium, strontium, barium, cesium, magnesium, and manganese. The ion exchange resulting from the presence of the salt is useful in aiding in the shrinkage of the rock.
- Optionally, including surfactants in the embrittlement modification agents may facilitate ultra low surface tensions and allow these fluids to penetrate into a subterranean formation more easily, e.g., via microfractures and between mineral platelets.
- The term “microparticles” as used herein refers to particles less than 500 microns in one dimension, but larger than nanoparticles. The term “nanoparticles” as used herein refers to particles with at least one dimension less than about 100 nm.
- Nearly all microparticles and combinations thereof known in the art that are suitable for use in subterranean operations and can adsorb and/or bind to minerals may be used in the methods of the present invention. Examples of suitable microparticles may include, but not be limited to, metal oxide microparticles like silica, titania, alumina, magnesium oxide, calcium oxide, and the like; minerals like slag, zeolite, vitrified shale, silica flour, silica sand; polymeric microparticles including those that comprise the polymers and/or resins disclosed herein; or any combination thereof.
- Nearly all nanoparticles and combinations thereof known in the art that are suitable for use in subterranean operations and can adsorb and/or bind to minerals may be used in the methods of the present invention. Examples of suitable nanoparticles may include, but not be limited to, carbon nanoparticles like fullerenes (spherical or otherwise), endofullerenes, nanotubes (single or multi-walled), filled nanotubes, carbon nanohorns, carbon nano-bamboo, graphene (single to few layer thick), and carbon quantum dots; metal oxide nanoparticles like silica, titania, alumina, iron oxide, manganese oxide, zinc oxide, molybdenum oxide, magnesium oxide, and calcium oxide; metal nanoparticles like gold, palladium, silver, and palladium; nitride nanoparticles; carbide nanoparticles; magnetic nanoparticles like Fe3O4 and gamma-Fe2O3; quantum dots like CdSe and ZnS; any derivative thereof; and any combination thereof. It should be noted that nanoparticles include nanorods, nanospheres, nanorices, nanowires, nanostars (like nanotripods and nanotetrapods), hollow nanostructures, hybrid nanostructures that are two or more nanoparticles connected as one, and non-nano particles with nano-coatings or nano-thick walls. It should be further noted that nanoparticles include the functionalized derivatives of nanoparticles including, but not limited to, nanoparticles that have been functionalized covalently and/or non-covalently, e.g., pi-stacking, physisorption, ionic association, van der Waals association, and the like. Suitable functional groups may include, but not be limited to, moieties comprising amines (1°, 2°, or 3°), amides, carboxylic acids, aldehydes, ketones, ethers, esters, peroxides, silyls, organosilanes, hydrocarbons, aromatic hydrocarbons, and any combination thereof; polymers; chelating agents like ethylenediamine tetraacetate, diethylenetriaminepentaacetic acid, triglycollamic acid, and a structure comprising a pyrrole ring; and any combination thereof.
- As described above, the various fluids described herein may comprise proppants. Proppants suitable for use in the present invention may comprise any material suitable for use in subterranean operations. Suitable materials for these proppants include, but are not limited to, sand, bauxite, ceramic materials, glass materials, polymer materials, polytetrafluoroethylene materials, nut shell pieces, cured resinous particulates comprising nut shell pieces, seed shell pieces, cured resinous particulates comprising seed shell pieces, fruit pit pieces, cured resinous particulates comprising fruit pit pieces, wood, composite particulates, and combinations thereof. Suitable composite particulates may comprise a binder and a filler material wherein suitable filler materials include silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly ash, hollow glass microspheres, solid glass, and combinations thereof. The mean particulate size generally may range from about 2 mesh to about 400 mesh on the U.S. Sieve Series; however, in certain circumstances, other mean particulate sizes may be desired and will be entirely suitable for practice of the present invention. In particular embodiments, preferred mean particulates size distribution ranges are one or more of 6/12, 8/16, 12/20, 16/30, 20/40, 30/50, 40/60, 40/70, or 50/70 mesh. It should be understood that the term “particulate,” as used in this disclosure, includes all known shapes of materials, including substantially spherical materials, fibrous materials, polygonal materials (such as cubic materials), and combinations thereof. Moreover, fibrous materials, that may or may not be used to bear the pressure of a closed fracture, may be included in certain embodiments of the present invention. In certain embodiments, the proppant may be present in the various fluids described herein in an amount in the range of from about 0.5 pounds per gallon (“ppg”) to about 30 ppg by volume of the treatment fluid, and encompass any subset therebetween.
- The base fluid of a leading-edge fluid, transition fluid, and/or treatment fluid may comprise oil-based fluids, aqueous-based fluids, aqueous-miscible fluids, water-in-oil emulsions, or oil-in-water emulsions. Suitable oil-based fluids may include alkanes, olefins, aromatic organic compounds, cyclic alkanes, paraffins, diesel fluids, mineral oils, desulfurized hydrogenated kerosenes, and any combination thereof.
- Suitable aqueous-based fluids may include fresh water, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated salt water), seawater, and any combination thereof. Generally, the water may be from any source, provided that it does not contain components that might adversely affect the stability and/or performance of the leading-edge fluid or the fracturing fluid of the present invention. In certain embodiments, the density of the aqueous base fluid can be adjusted, among other purposes, to provide additional particulate transport and suspension in the leading-edge fluid or the fracturing fluid used in the methods of the present invention. In certain embodiments, the pH of the aqueous base fluid may be adjusted (e.g., by a buffer or other pH adjusting agent), among other purposes, to reduce the viscosity of the leading-edge fluid or fracturing fluid. In these embodiments, the pH may be adjusted to a specific level, which may depend on, among other factors, the types of gelling agents, acids, and other additives included in the leading-edge fluid or fracturing fluid. One of ordinary skill in the art, with the benefit of this disclosure, will recognize when such density and/or pH adjustments are appropriate.
- Suitable aqueous-miscible fluids may include, but not be limited to, alcohols, e.g., methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, and t-butanol; glycerins; glycols, e.g., polyglycols, propylene glycol, and ethylene glycol; polyglycol amines; polyols; any derivative thereof; any in combination with salts, e.g., sodium chloride, calcium chloride, calcium bromide, zinc bromide, potassium carbonate, sodium formate, potassium formate, cesium formate, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, ammonium chloride, ammonium bromide, sodium nitrate, potassium nitrate, ammonium nitrate, ammonium sulfate, calcium nitrate, sodium carbonate, and potassium carbonate; any in combination with an aqueous-based fluid; and any combination thereof.
- Suitable water-in-oil emulsions, also known as invert emulsions, may have an oil-to-water ratio from a lower limit of greater than about 50:50, 55:45, 60:40, 65:35, 70:30, 75:25, or 80:20 to an upper limit of less than about 100:0, 95:5, 90:10, 85:15, 80:20, 75:25, 70:30, or 65:35 by volume in the base treatment fluid, and wherein the amount may range from any lower limit to any upper limit and encompass any subset therebetween. Examples of suitable invert emulsions include those disclosed in U.S. Pat. No. 5,905,061, U.S. Pat. No. 5,977,031, and U.S. Pat. No. 6,828,279, each of which are incorporated herein by reference. It should be noted that for water-in-oil and oil-in-water emulsions, any mixture of the above may be used including the water being an aqueous-miscible fluid.
- In some embodiments, the base fluid may be foamed, i.e., may comprise a foaming agent and a gas. Suitable foaming agents may be any known foaming agent that does not cause deleterious chemical and/or physical changes to the formation faces and may be used in a sufficient amount to achieve a desired foam, which should be known to one skilled in the art. In some embodiments, the gas is selected from the group consisting of nitrogen, carbon dioxide, air, methane, helium, argon, and any combination thereof. In some embodiments, the quality of the foamed fracturing fluid may range from a lower limit of about 5%, 10%, 25%, 40%, 50%, 60%, or 70% gas volume to an upper limit of about 99%, 90%, 80%, 75%, 60%, or 50% gas volume, and wherein the quality of the foamed fracturing fluid may range from any lower limit to any upper limit and encompass any subset therebetween.
- The various fluids described herein can further comprise additives including, but not limited to, salts, weighting agents, inert solids, fluid loss control agents, emulsifiers, dispersion aids, corrosion inhibitors, emulsion thinners, emulsion thickeners, viscosifying agents, high-pressure and high-temperature emulsifier-filtration control agents, surfactants, particulates, proppants, lost circulation materials, foaming agents, gases, pH control additives, breakers, biocides, crosslinkers, stabilizers, scale inhibitors, mutual solvents, oxidizers, reducers, friction reducers, and any combination thereof.
- In some embodiments, a method of desensitizing a subterranean formation may generally include the steps of: introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- In some embodiments, a method of remedially desensitizing a subterranean formation may generally include the steps of: providing a wellbore penetrating a subterranean formation that comprises a plurality of formation faces, the formation faces having undergone deleterious chemical and/or physical changes; introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
- In some embodiments, a method of desensitizing a subterranean formation may generally include the steps of: providing a wellbore penetrating a subterranean formation; introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into a first portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into the first portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration; then diverting fluid flow from the first portion of the subterranean formation to a second portion of the subterranean formation; then introducing a second leading-edge fluid comprising a third base fluid and a third desensitizing agent into the second portion of the subterranean formation, wherein the third desensitizing agent is present in the third base fluid at a third concentration; and then second introducing a treatment fluid comprising a fourth base fluid and a fourth desensitizing agent into the second portion of the subterranean formation, wherein the fourth desensitizing agent is present in the fourth base fluid at a second concentration, and wherein the third concentration is higher than the fourth concentration.
- It should be noted that while this disclosure is drawn to desensitizing problematic formations, one skilled in the art with the benefit of this disclosure could adapt the methods provided herein for other multi-stage treatments of subterranean formations. Further many of the advantages disclosed herein may translate to the adapted methods including, but not limited to, effective penetration of a treatment deeper into the subterranean formation while decreasing the overall concentration of treatment fluid components. This reduction in the amount of treatment fluid components used can result in a significant cost savings for the operator and may help reduce the environmental impact of the treatment.
- To facilitate a better understanding of the present invention, the following examples of preferred embodiments are given. In no way should the following examples be read to limit, or to define, the scope of the invention.
- X-Ray analysis of the field shale samples in South Texas revealed a clay concentration of about 40% to 50% with about 1% of the clay content identified as swelling clay. Based on this information, the following treatment recommendations were made:
- (a)
Use 1% v/v of CLA-WEB™ clay-stabilization additive in the first 5% of the fracturing treatment volume as the spearhead fluid. Thus, for a 500,000-gal fracturing treatment volume, an amount of 250 gal of CLA-WEB™ clay-stabilization additive was used in mixing with 25,000 gal of fresh water to prepare the 1% v/v CLA-WEB™ clay-stabilization additive solution. - (b) Use 0.05% v/v of CLA-WEB™ clay-stabilization additive in the remainder of the fracturing treatment volume, or mix 250 gal of CLA-WEB™ clay-stabilization additive with the remaining 475,000 gal of fluid.
- For a well located in Saudi, X-ray diffraction analysis (Table 1) indicates only trace amounts of smectite clay in the obtained shale samples with a significant amount of mixed layers which may contain swelling clays.
-
TABLE 1 Interval Depth 13,419.3′ 13,582.5′ Quartz 37% 46% K- feldspar 3% 3% Na- feldspar 3% 4% Dolomite 27% 2% Pyrite 6% 6 % Kaolinite 3% 3% Chlorite trace trace Muscovite trace 1% Illite 12% 22% Mixed layer 7% 7% Smectite trace trace - Shale samples of the two intervals were crushed and sieved to obtained mesh size less than 200 U.S. mesh. Equal amounts of each sample was mixed to form a homogeneous blend which was used to form a sand pack column with the composition of 85% (w/w) of 70/170-mesh quartz sand, 10%(w/w) of silica flour, and 5% (w/w) of crushed, mixed shale samples. Flow tests were performed through the packed columns to evaluate the desensitize performance of 1% (v/v) and 3% (v/v) CLA-WEB™ clay-stabilization additive solutions. The series of treatment fluids and volumes are listed in Table 2. All fluids were injected through the column at 10 mL/min flow rate.
-
TABLE 2 Injected Fluids Injected Volume (mL) 3% KCl brine 100 3% CLA-WEB ™ clay- 200 stabilization additive 3% KCl brine 50 Fresh water 60 3% KCl brine 100 - A decrease in permeability of brine after exposure to fresh water comparing with brine pressure after treatment of 1% CLA-WEB™ clay-stabilization additive solution indicates that this 1% CLA-WEB™ clay-stabilization additive concentration was not sufficient for clay protection, which will result in permeability reduction. The treatment with 3% CLA-WEB™ clay-stabilization additive solution indicates this CLA-WEB™ clay-stabilization additive concentration was more appropriate to minimize any potential of permeability damage.
- Based on the results of these tests, it was recommended that a concentration of 5% (v/v) of CLA-WEB™ clay-stabilization additive be used in the pad fluid of the fracturing treatment, and a concentration of 0.2% (v/v) of CLA-WEB™ clay-stabilization additive be used in the remainder of the fracturing fluid carrying proppant.
- Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered, combined, or modified and all such variations are considered within the scope and spirit of the present invention. While compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. All numbers and ranges disclosed above may vary by some amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee. Moreover, the indefinite articles “a” or “an,” as used in the claims, are defined herein to mean one or more than one of the element that it introduces. If there is any conflict in the usages of a word or term in this specification and one or more patent or other documents that may be incorporated herein by reference, the definitions that are consistent with this specification should be adopted.
Claims (19)
1. A method of desensitizing a subterranean formation, the method comprising:
providing a wellbore penetrating a subterranean formation;
introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and
then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
2. The method of claim 1 , wherein the first concentration ranges from about 0.01% to about 60% v/v of the first desensitizing agent to the first base fluid.
3. The method of claim 1 , wherein the first concentration changes over time in a manner selected from the group consisting of a gradient change, a step-wise change, and any combination thereof.
4. The method of claim 1 , wherein the first concentration is about 2 to about 5000 times greater than the second concentration.
5. The method of claim 1 , wherein the second concentration ranges from about 0.0001% to about 20% v/v of the second desensitizing agent to the second base fluid.
6. The method of claim 1 , wherein the second concentration changes over time in a manner selected from the group consisting of a gradient change, a step-wise change, and any combination thereof.
7. The method of claim 1 further comprising:
introducing a transition fluid comprising a third base fluid and a third desensitizing solution that comprises a third desensitizing agent between the introduction of the leading-edge fluid and the treatment fluid, wherein the third desensitizing agent is present in the third base fluid at a third concentration.
8. The method of claim 7 , wherein the third concentration changes over time in a manner selected from the group consisting of a gradient change, a step-wise change, and any combination thereof.
9. The method of claim 1 , wherein the first desensitizing agent comprises at least one selected from the group consisting of: an inorganic acid, a salt, a polyelectrolyte, a multivalent ion, an inorganic base, a strong base, an oxide, a resin, a surfactant, a cationic polymer, a methyl glucoside, a polyglycerol, a polyglycol, an emulsion facilitating particle, a chelating agent, a phosphine, a soluble organic stabilizing compound, a silica control agent, an embrittlement modification agent, a surface modification agent, a microparticle, a nanoparticle, and any combination thereof.
10. The method of claim 1 , wherein the second desensitizing agent comprises at least one selected from the group consisting of: an inorganic acid, a salt, a polyelectrolyte, a multivalent ion, an inorganic base, a strong base, an oxide, a resin, a surfactant, a cationic polymer, a methyl glucoside, a polyglycerol, a polyglycol, an emulsion facilitating particle, a chelating agent, a phosphine, a soluble organic stabilizing compound, a silica control agent, an embrittlement modification agent, a surface modification agent, a microparticle, a nanoparticle, and any combination thereof.
11. The method of claim 1 , wherein the first desensitizing agent and the second desensitizing agent are different compositions.
12. The method of claim 1 , wherein the leading-edge fluid and treatment fluid contain a same desensitizing agent such that the same desensitizing agent is from about 0.01% to about 60% v/v in the leading-edge fluid and the same desensitizing agent is from about 0.0001% to about 20% v/v in the treatment fluid.
13. The method of claim 1 , wherein introducing the leading-edge fluid is performed at a fracture pressure.
14. The method of claim 1 , wherein the leading-edge fluid further comprises a proppant.
15. The method of claim 1 , wherein introducing the treatment fluid is performed at a fracture pressure.
16. The method of claim 1 , wherein the treatment fluid further comprises a proppant.
17. A method of remedially desensitizing a subterranean formation, the method comprising:
providing a wellbore penetrating a subterranean formation that comprises a plurality of formation faces, the formation faces having undergone deleterious chemical and/or physical changes;
introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into at least a portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration; and
then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into at least a portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration.
18. A method of desensitizing a subterranean formation, the method comprising:
providing a wellbore penetrating a subterranean formation;
introducing a leading-edge fluid comprising a first base fluid and a first desensitizing agent into a first portion of the subterranean formation, wherein the first desensitizing agent is present in the first base fluid at a first concentration;
then introducing a treatment fluid comprising a second base fluid and a second desensitizing agent into the first portion of the subterranean formation, wherein the second desensitizing agent is present in the second base fluid at a second concentration, and wherein the first concentration is higher than the second concentration;
then diverting fluid flow from the first portion of the subterranean formation to a second portion of the subterranean formation;
then introducing a second leading-edge fluid comprising a third base fluid and a third desensitizing agent into the second portion of the subterranean formation, wherein the third desensitizing agent is present in the third base fluid at a third concentration; and
then second introducing a treatment fluid comprising a fourth base fluid and a fourth desensitizing agent into the second portion of the subterranean formation, wherein the fourth desensitizing agent is present in the fourth base fluid at a second concentration, and wherein the third concentration is higher than the fourth concentration.
19. The method of claim 18 , wherein diverting the fluid flow involves at least one selected from the group consisting of: a plugging agent, a plug, a packer, a bridge plug, a frac plug, plugging agent, a perf ball, a gel, a plugging foam, a diverting agent, a degradable diverting agent, and any combination thereof.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/239,491 US20120285690A1 (en) | 2011-05-12 | 2011-09-22 | Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces |
CA2848198A CA2848198A1 (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
RU2014114989/03A RU2014114989A (en) | 2011-09-22 | 2012-08-21 | MULTISTAGE WAYS AND COMPOSITIONS FOR DESENIBILIZATION OF SURFACES OF UNDERGROUND LAYERS |
PCT/US2012/051688 WO2013043292A1 (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
MYPI2014000459A MY159793A (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
EP12756851.7A EP2758487A1 (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
CN201280046516.9A CN103842470A (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
AU2012312973A AU2012312973B2 (en) | 2011-09-22 | 2012-08-21 | Multi-stage methods and compositions for desensitizing subterranean formations faces |
ARP120103437A AR087911A1 (en) | 2011-09-22 | 2012-09-18 | METHODS IN MULTIPLE STAGES AND COMPOSITIONS TO DISENSITIZE THE FACES OF UNDERGROUND FORMATIONS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/106,382 US8757261B2 (en) | 2011-05-12 | 2011-05-12 | Methods and compositions for clay control |
US13/239,491 US20120285690A1 (en) | 2011-05-12 | 2011-09-22 | Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/106,382 Continuation-In-Part US8757261B2 (en) | 2011-05-12 | 2011-05-12 | Methods and compositions for clay control |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120285690A1 true US20120285690A1 (en) | 2012-11-15 |
Family
ID=47141098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/239,491 Abandoned US20120285690A1 (en) | 2011-05-12 | 2011-09-22 | Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces |
Country Status (1)
Country | Link |
---|---|
US (1) | US20120285690A1 (en) |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103242812A (en) * | 2013-05-20 | 2013-08-14 | 西南石油大学 | Switchable foaming solution for foam drilling and well cleanup on oil and gas field |
US20140290958A1 (en) * | 2013-03-27 | 2014-10-02 | Halliburton Energy Services, Inc. | Use of Nanoparticles in Cleaning Well Bores |
US20150090456A1 (en) * | 2012-04-15 | 2015-04-02 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk | Fluorescent nano-sensors for oil and gas reservoir characterization |
CN104559969A (en) * | 2014-12-17 | 2015-04-29 | 中国科学院广州能源研究所 | Deepwater drilling fluid |
US20150129225A1 (en) * | 2012-06-07 | 2015-05-14 | University Of Leeds | Method of inhibiting scale in a geological formation |
US20150144347A1 (en) * | 2013-11-27 | 2015-05-28 | Baker Hughes Incorporated | System and Method for Re-fracturing Multizone Horizontal Wellbores |
US9068108B2 (en) | 2013-03-14 | 2015-06-30 | Cesi Chemical, Inc. | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US9200192B2 (en) | 2012-05-08 | 2015-12-01 | Cesi Chemical, Inc. | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons |
US9222013B1 (en) | 2008-11-13 | 2015-12-29 | Cesi Chemical, Inc. | Water-in-oil microemulsions for oilfield applications |
US9321955B2 (en) | 2013-06-14 | 2016-04-26 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US9366125B2 (en) | 2013-09-11 | 2016-06-14 | Saudi Arabian Oil Company | Carbonate based slurry fracturing using solid acid for unconventional reservoirs |
WO2016108895A1 (en) * | 2014-12-31 | 2016-07-07 | Halliburton Energy Services, Inc. | Emulsified acidic treatment fluid with surface modification agents |
US9428683B2 (en) | 2013-03-14 | 2016-08-30 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US9464223B2 (en) | 2013-03-14 | 2016-10-11 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
AU2015284032A1 (en) * | 2014-07-02 | 2016-11-24 | Halliburton Energy Services, Inc. | Injecting polyelectrolyte based sacrificial agents for use in unconventional formations |
US9505970B2 (en) | 2014-05-14 | 2016-11-29 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US9562188B2 (en) | 2013-09-20 | 2017-02-07 | Baker Hughes Incorporated | Composites for use in stimulation and sand control operations |
US9683431B2 (en) | 2013-09-20 | 2017-06-20 | Baker Hughes Incorporated | Method of using surface modifying metallic treatment agents to treat subterranean formations |
US9701892B2 (en) | 2014-04-17 | 2017-07-11 | Baker Hughes Incorporated | Method of pumping aqueous fluid containing surface modifying treatment agent into a well |
US9822621B2 (en) | 2013-09-20 | 2017-11-21 | Baker Hughes, A Ge Company, Llc | Method of using surface modifying treatment agents to treat subterranean formations |
US9868893B2 (en) | 2013-03-14 | 2018-01-16 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US9884988B2 (en) | 2013-03-14 | 2018-02-06 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US9890625B2 (en) | 2014-02-28 | 2018-02-13 | Eclipse Ior Services, Llc | Systems and methods for the treatment of oil and/or gas wells with an obstruction material |
US9890624B2 (en) | 2014-02-28 | 2018-02-13 | Eclipse Ior Services, Llc | Systems and methods for the treatment of oil and/or gas wells with a polymeric material |
US9951264B2 (en) | 2012-04-15 | 2018-04-24 | Flotek Chemistry, Llc | Surfactant formulations for foam flooding |
US9957779B2 (en) | 2014-07-28 | 2018-05-01 | Flotek Chemistry, Llc | Methods and compositions related to gelled layers in oil and/or gas wells |
US10000693B2 (en) | 2013-03-14 | 2018-06-19 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10047280B2 (en) | 2013-09-20 | 2018-08-14 | Baker Hughes, A Ge Company, Llc | Organophosphorus containing composites for use in well treatment operations |
US10053619B2 (en) | 2013-03-14 | 2018-08-21 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
US10077606B2 (en) * | 2013-03-27 | 2018-09-18 | Halliburton Energy Services, Inc. | Methods of mitigating bituminous material adhesion using nano-particles |
US10155899B2 (en) * | 2015-06-19 | 2018-12-18 | Baker Hughes Incorporated | Methods of forming suspensions and methods for recovery of hydrocarbon material from subterranean formations |
US10167392B2 (en) | 2014-10-31 | 2019-01-01 | Baker Hughes Incorporated | Compositions of coated diamond nanoparticles, methods of forming coated diamond nanoparticles, and methods of forming coatings |
CN109401745A (en) * | 2018-11-21 | 2019-03-01 | 西南石油大学 | A kind of adaptive mobility control system and its application in high temperature and high salt oil deposit |
US10227846B2 (en) | 2013-09-20 | 2019-03-12 | Baker Hughes, A Ge Company, Llc | Method of inhibiting fouling on a metallic surface using a surface modifying treatment agent |
US10287483B2 (en) | 2013-03-14 | 2019-05-14 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells comprising a terpene alcohol |
US10421707B2 (en) | 2013-03-14 | 2019-09-24 | Flotek Chemistry, Llc | Methods and compositions incorporating alkyl polyglycoside surfactant for use in oil and/or gas wells |
US10421898B2 (en) | 2015-12-17 | 2019-09-24 | Saudi Arabian Oil Company | Targeting enhanced production through deep carbonate stimulation: stabilized acid emulsions containing insoluble solid materials with desired wetting properties |
WO2019221693A1 (en) * | 2018-05-14 | 2019-11-21 | Halliburton Energy Services, Inc. | Pelletized diverting agents using degradable polymers |
US10577531B2 (en) | 2013-03-14 | 2020-03-03 | Flotek Chemistry, Llc | Polymers and emulsions for use in oil and/or gas wells |
US10590332B2 (en) | 2013-03-14 | 2020-03-17 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
WO2020106866A1 (en) * | 2018-11-20 | 2020-05-28 | Baker Hughes, A Ge Company, Llc | Oil-based fluid compositions with enhanced electrical conductivity |
US10669635B2 (en) | 2014-09-18 | 2020-06-02 | Baker Hughes, A Ge Company, Llc | Methods of coating substrates with composite coatings of diamond nanoparticles and metal |
US10717919B2 (en) | 2013-03-14 | 2020-07-21 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10934472B2 (en) | 2017-08-18 | 2021-03-02 | Flotek Chemistry, Llc | Compositions comprising non-halogenated solvents for use in oil and/or gas wells and related methods |
US10941106B2 (en) | 2013-03-14 | 2021-03-09 | Flotek Chemistry, Llc | Methods and compositions incorporating alkyl polyglycoside surfactant for use in oil and/or gas wells |
US11053433B2 (en) | 2017-12-01 | 2021-07-06 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US11084974B2 (en) | 2018-08-29 | 2021-08-10 | Championx Usa Inc. | Use of multiple charged cationic compounds derived from polyamines for clay stabilization in oil and gas operations |
US11104843B2 (en) | 2019-10-10 | 2021-08-31 | Flotek Chemistry, Llc | Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency |
US11180690B2 (en) | 2013-03-14 | 2021-11-23 | Flotek Chemistry, Llc | Diluted microemulsions with low surface tensions |
US11254856B2 (en) | 2013-03-14 | 2022-02-22 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US11407930B2 (en) | 2012-05-08 | 2022-08-09 | Flotek Chemistry, Llc | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons |
US11512243B2 (en) | 2020-10-23 | 2022-11-29 | Flotek Chemistry, Llc | Microemulsions comprising an alkyl propoxylated sulfate surfactant, and related methods |
US20230037819A1 (en) * | 2019-12-16 | 2023-02-09 | Championx Usa Inc. | Surface-modified nanoparticle compositions and related applications in subterranean hydrocarbon recovery |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009880A1 (en) * | 2002-07-09 | 2004-01-15 | Diankui Fu | Self-diverting pre-flush acid for sandstone |
US20070029085A1 (en) * | 2005-08-05 | 2007-02-08 | Panga Mohan K | Prevention of Water and Condensate Blocks in Wells |
US7196040B2 (en) * | 2000-06-06 | 2007-03-27 | T R Oil Services Limited | Microcapsule well treatment |
-
2011
- 2011-09-22 US US13/239,491 patent/US20120285690A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7196040B2 (en) * | 2000-06-06 | 2007-03-27 | T R Oil Services Limited | Microcapsule well treatment |
US20040009880A1 (en) * | 2002-07-09 | 2004-01-15 | Diankui Fu | Self-diverting pre-flush acid for sandstone |
US20070029085A1 (en) * | 2005-08-05 | 2007-02-08 | Panga Mohan K | Prevention of Water and Condensate Blocks in Wells |
Cited By (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10280360B2 (en) | 2008-11-13 | 2019-05-07 | Flotek Chemistry, Llc | Water-in-oil microemulsions for oilfield applications |
US9222013B1 (en) | 2008-11-13 | 2015-12-29 | Cesi Chemical, Inc. | Water-in-oil microemulsions for oilfield applications |
US9494023B2 (en) * | 2012-04-15 | 2016-11-15 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Nano-sensors for oil and gas reservoir characterization |
US20150090456A1 (en) * | 2012-04-15 | 2015-04-02 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk | Fluorescent nano-sensors for oil and gas reservoir characterization |
US9951264B2 (en) | 2012-04-15 | 2018-04-24 | Flotek Chemistry, Llc | Surfactant formulations for foam flooding |
US10144862B2 (en) | 2012-05-08 | 2018-12-04 | Flotek Chemistry, Llc | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons |
US9200192B2 (en) | 2012-05-08 | 2015-12-01 | Cesi Chemical, Inc. | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons |
US11407930B2 (en) | 2012-05-08 | 2022-08-09 | Flotek Chemistry, Llc | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons |
US20150129225A1 (en) * | 2012-06-07 | 2015-05-14 | University Of Leeds | Method of inhibiting scale in a geological formation |
US9890623B2 (en) * | 2012-06-07 | 2018-02-13 | University Of Leeds | Method of inhibiting scale in a geological formation |
US9884988B2 (en) | 2013-03-14 | 2018-02-06 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10717919B2 (en) | 2013-03-14 | 2020-07-21 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US11560351B2 (en) | 2013-03-14 | 2023-01-24 | Flotek Chemistry, Llc | Methods and compositions incorporating alkyl polyglycoside surfactant for use in oil and/or gas wells |
US9428683B2 (en) | 2013-03-14 | 2016-08-30 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US9464223B2 (en) | 2013-03-14 | 2016-10-11 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10544355B2 (en) | 2013-03-14 | 2020-01-28 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations using emulsions comprising terpene |
US10590332B2 (en) | 2013-03-14 | 2020-03-17 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
US11254856B2 (en) | 2013-03-14 | 2022-02-22 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10703960B2 (en) | 2013-03-14 | 2020-07-07 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US11180690B2 (en) | 2013-03-14 | 2021-11-23 | Flotek Chemistry, Llc | Diluted microemulsions with low surface tensions |
US10421707B2 (en) | 2013-03-14 | 2019-09-24 | Flotek Chemistry, Llc | Methods and compositions incorporating alkyl polyglycoside surfactant for use in oil and/or gas wells |
US10053619B2 (en) | 2013-03-14 | 2018-08-21 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
US10287483B2 (en) | 2013-03-14 | 2019-05-14 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells comprising a terpene alcohol |
US9850418B2 (en) | 2013-03-14 | 2017-12-26 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US9868893B2 (en) | 2013-03-14 | 2018-01-16 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10577531B2 (en) | 2013-03-14 | 2020-03-03 | Flotek Chemistry, Llc | Polymers and emulsions for use in oil and/or gas wells |
US10731071B2 (en) | 2013-03-14 | 2020-08-04 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells comprising microemulsions with terpene, silicone solvent, and surfactant |
US9068108B2 (en) | 2013-03-14 | 2015-06-30 | Cesi Chemical, Inc. | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US10941106B2 (en) | 2013-03-14 | 2021-03-09 | Flotek Chemistry, Llc | Methods and compositions incorporating alkyl polyglycoside surfactant for use in oil and/or gas wells |
US11634625B2 (en) | 2013-03-14 | 2023-04-25 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
US11149189B2 (en) | 2013-03-14 | 2021-10-19 | Flotek Chemistry, Llc | Siloxane surfactant additives for oil and gas applications |
US11034879B2 (en) | 2013-03-14 | 2021-06-15 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US9994762B2 (en) | 2013-03-14 | 2018-06-12 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US10000693B2 (en) | 2013-03-14 | 2018-06-19 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10801305B2 (en) | 2013-03-27 | 2020-10-13 | Halliburton Energy Services, Inc. | Use of nanoparticles in cleaning well bores |
US20140290958A1 (en) * | 2013-03-27 | 2014-10-02 | Halliburton Energy Services, Inc. | Use of Nanoparticles in Cleaning Well Bores |
US10974289B2 (en) | 2013-03-27 | 2021-04-13 | Halliburton Energy Services, Inc. | Methods of mitigating bituminous material adhesion using nano-particles |
US10077606B2 (en) * | 2013-03-27 | 2018-09-18 | Halliburton Energy Services, Inc. | Methods of mitigating bituminous material adhesion using nano-particles |
US10077636B2 (en) * | 2013-03-27 | 2018-09-18 | Halliburton Energy Services, Inc. | Use of nanoparticles in cleaning well bores |
CN103242812A (en) * | 2013-05-20 | 2013-08-14 | 西南石油大学 | Switchable foaming solution for foam drilling and well cleanup on oil and gas field |
US9321955B2 (en) | 2013-06-14 | 2016-04-26 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US10196557B2 (en) | 2013-06-14 | 2019-02-05 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US10738235B2 (en) | 2013-06-14 | 2020-08-11 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US9366125B2 (en) | 2013-09-11 | 2016-06-14 | Saudi Arabian Oil Company | Carbonate based slurry fracturing using solid acid for unconventional reservoirs |
US9822621B2 (en) | 2013-09-20 | 2017-11-21 | Baker Hughes, A Ge Company, Llc | Method of using surface modifying treatment agents to treat subterranean formations |
US10227846B2 (en) | 2013-09-20 | 2019-03-12 | Baker Hughes, A Ge Company, Llc | Method of inhibiting fouling on a metallic surface using a surface modifying treatment agent |
US10047280B2 (en) | 2013-09-20 | 2018-08-14 | Baker Hughes, A Ge Company, Llc | Organophosphorus containing composites for use in well treatment operations |
US9683431B2 (en) | 2013-09-20 | 2017-06-20 | Baker Hughes Incorporated | Method of using surface modifying metallic treatment agents to treat subterranean formations |
US9562188B2 (en) | 2013-09-20 | 2017-02-07 | Baker Hughes Incorporated | Composites for use in stimulation and sand control operations |
US20150144347A1 (en) * | 2013-11-27 | 2015-05-28 | Baker Hughes Incorporated | System and Method for Re-fracturing Multizone Horizontal Wellbores |
US9366124B2 (en) * | 2013-11-27 | 2016-06-14 | Baker Hughes Incorporated | System and method for re-fracturing multizone horizontal wellbores |
US9890625B2 (en) | 2014-02-28 | 2018-02-13 | Eclipse Ior Services, Llc | Systems and methods for the treatment of oil and/or gas wells with an obstruction material |
US9890624B2 (en) | 2014-02-28 | 2018-02-13 | Eclipse Ior Services, Llc | Systems and methods for the treatment of oil and/or gas wells with a polymeric material |
US9701892B2 (en) | 2014-04-17 | 2017-07-11 | Baker Hughes Incorporated | Method of pumping aqueous fluid containing surface modifying treatment agent into a well |
US9505970B2 (en) | 2014-05-14 | 2016-11-29 | Flotek Chemistry, Llc | Methods and compositions for use in oil and/or gas wells |
US10066157B2 (en) * | 2014-07-02 | 2018-09-04 | Halliburton Energy Services, Inc. | Injecting polyelectrolyte based sacrificial agents for use in unconventional formations |
AU2015284032A1 (en) * | 2014-07-02 | 2016-11-24 | Halliburton Energy Services, Inc. | Injecting polyelectrolyte based sacrificial agents for use in unconventional formations |
AU2015284032B2 (en) * | 2014-07-02 | 2017-04-20 | Halliburton Energy Services, Inc. | Injecting polyelectrolyte based sacrificial agents for use in unconventional formations |
US9969928B2 (en) | 2014-07-02 | 2018-05-15 | Multi-Chem Group, Llc | Surfactant formulations and associated methods for reduced and delayed adsorption of the surfactant |
US10294757B2 (en) | 2014-07-28 | 2019-05-21 | Flotek Chemistry, Llc | Methods and compositions related to gelled layers in oil and/or gas wells |
US9957779B2 (en) | 2014-07-28 | 2018-05-01 | Flotek Chemistry, Llc | Methods and compositions related to gelled layers in oil and/or gas wells |
US10669635B2 (en) | 2014-09-18 | 2020-06-02 | Baker Hughes, A Ge Company, Llc | Methods of coating substrates with composite coatings of diamond nanoparticles and metal |
US10167392B2 (en) | 2014-10-31 | 2019-01-01 | Baker Hughes Incorporated | Compositions of coated diamond nanoparticles, methods of forming coated diamond nanoparticles, and methods of forming coatings |
CN104559969A (en) * | 2014-12-17 | 2015-04-29 | 中国科学院广州能源研究所 | Deepwater drilling fluid |
WO2016108895A1 (en) * | 2014-12-31 | 2016-07-07 | Halliburton Energy Services, Inc. | Emulsified acidic treatment fluid with surface modification agents |
US20190048251A1 (en) * | 2015-06-19 | 2019-02-14 | Baker Hughes, A Ge Company, Llc | Suspensions for removing hydrocarbons from subterranean formations and related methods |
US10155899B2 (en) * | 2015-06-19 | 2018-12-18 | Baker Hughes Incorporated | Methods of forming suspensions and methods for recovery of hydrocarbon material from subterranean formations |
US10421898B2 (en) | 2015-12-17 | 2019-09-24 | Saudi Arabian Oil Company | Targeting enhanced production through deep carbonate stimulation: stabilized acid emulsions containing insoluble solid materials with desired wetting properties |
US10894915B2 (en) | 2015-12-17 | 2021-01-19 | Saudi Arabian Oil Company | Targeting enhanced production through deep carbonate stimulation: stabilized acid emulsions containing insoluble solid materials with desired wetting properties |
US10934472B2 (en) | 2017-08-18 | 2021-03-02 | Flotek Chemistry, Llc | Compositions comprising non-halogenated solvents for use in oil and/or gas wells and related methods |
US11053433B2 (en) | 2017-12-01 | 2021-07-06 | Flotek Chemistry, Llc | Methods and compositions for stimulating the production of hydrocarbons from subterranean formations |
US11802231B2 (en) | 2018-05-14 | 2023-10-31 | Halliburton Energy Services, Inc. | Pelletized diverting agents using degradable polymers |
WO2019221693A1 (en) * | 2018-05-14 | 2019-11-21 | Halliburton Energy Services, Inc. | Pelletized diverting agents using degradable polymers |
US11572497B2 (en) | 2018-05-14 | 2023-02-07 | Halliburton Energy Services, Inc. | Pelletized diverting agents using degradable polymers |
US11084974B2 (en) | 2018-08-29 | 2021-08-10 | Championx Usa Inc. | Use of multiple charged cationic compounds derived from polyamines for clay stabilization in oil and gas operations |
US11702586B2 (en) | 2018-08-29 | 2023-07-18 | Championx Usa Inc. | Use of multiple charged cationic compounds derived from polyamines for clay stabilization in oil and gas operations |
WO2020106866A1 (en) * | 2018-11-20 | 2020-05-28 | Baker Hughes, A Ge Company, Llc | Oil-based fluid compositions with enhanced electrical conductivity |
CN109401745A (en) * | 2018-11-21 | 2019-03-01 | 西南石油大学 | A kind of adaptive mobility control system and its application in high temperature and high salt oil deposit |
US11104843B2 (en) | 2019-10-10 | 2021-08-31 | Flotek Chemistry, Llc | Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency |
US11597873B2 (en) | 2019-10-10 | 2023-03-07 | Flotek Chemistry, Llc | Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency |
US20230037819A1 (en) * | 2019-12-16 | 2023-02-09 | Championx Usa Inc. | Surface-modified nanoparticle compositions and related applications in subterranean hydrocarbon recovery |
US11512243B2 (en) | 2020-10-23 | 2022-11-29 | Flotek Chemistry, Llc | Microemulsions comprising an alkyl propoxylated sulfate surfactant, and related methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120285690A1 (en) | Multi-Stage Methods and Compositions for Desensitizing Subterranean Formations Faces | |
AU2012312973B2 (en) | Multi-stage methods and compositions for desensitizing subterranean formations faces | |
US8664168B2 (en) | Method of using composites in the treatment of wells | |
US9027647B2 (en) | Treatment fluids containing a biodegradable chelating agent and methods for use thereof | |
US9976070B2 (en) | Method of using shaped compressed pellets in well treatment operations | |
US8881811B2 (en) | Additives to suppress silica scale build-up and methods of use thereof | |
EP2917301B1 (en) | Alkylated polyetheramines as clay stabilizing agents | |
AU2012252122B2 (en) | Methods and compositions for clay control | |
US10822536B2 (en) | Method of using a screen containing a composite for release of well treatment agent into a well | |
US10961444B1 (en) | Method of using coated composites containing delayed release agent in a well treatment operation | |
US20110000672A1 (en) | Clay Stabilization with Nanoparticles | |
WO2015191027A1 (en) | Amido-amine based cationic gemini surfactants for clay inhibition | |
US9869156B2 (en) | Gellable treatment fluids with clay-based gel retarders and related methods | |
AU2016252607B2 (en) | Shaped compressed pellets for slow release of well treatment agents into a well and methods of using the same | |
WO2016144322A1 (en) | Treatment fluids comprising anhydrous ammonia for use in subterranean formation operations | |
US20120178651A1 (en) | Clay Stabilization With Nanoparticles | |
US9644135B2 (en) | Delayed curing silane-based curable resin system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HALLIBURTON ENERGY SERVICES, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEAVER, JIMMIE D.;NGUYEN, PHILIP D.;RICKMAN, RICHARD D.;REEL/FRAME:026946/0075 Effective date: 20110901 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |